Biography
Dr Noreen Gleeson M.D.graduated from the National University of Ireland (UCC) 1981, is a Member of Royal College Obstetricians & Gynaecologist (1986) and has a Diploma in Statistics (1989) and Doctor of Medicine (1991) from Trinity College Dublin. She undertook her Registrar training in Limerick, Rotunda and Adelaide Hospitals. She completed a two year clinical fellowship in Gynaecological Oncology at the University of South Florida in 1993 and has been working at Coombe Women's and St James's Hospitals since then. She is Director of the Gynaecological Oncology Fellowship RCOG Programme at St James's Hospital. Her major clinical interests are gynaecological cancer, complex and reconstructive pelvic surgery. Her laboratory based research is in thrombosis and haemostasis and molecular aspects of gynaecological malignancy. Google Scholar Citations 1856, h-index 25; https://scholar.google.com/citations? view_op=list_works&hl=en&user=fX222CoAAAAJ
Publications and Further Research Outputs
Peer-Reviewed Publications
Marchocki Z, Norris L, O'Toole S, Gleeson N, Abu Saadeh F, Patients' experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynaecological cancer. A prospective observational study, International Journal of Gynaecological Cancer. , 2019
Patrick Maguire; Aleksandra Sobota; Doug Mulholland; Ryan, J. Mark; Noreen Gleeson, Ureteric Obstruction: Clinical Profile of a common complication in women with cervical cancer , BGCS, British Gynaecological Cancer Society , London, July 2018, 2018
Z. Marchocki, N. Gleeson, F. Abu Saadeh, M.P. Ward, S.A. O'Toole, L.A. Norris, Fibrinogen, D-Dimers and thrombin generation assays as predictors of the risk of recurrent VTE in patients with gynaecological malignancies, Thrombosis Research, International Congress on Thrombosis and Haemostasis Issues in Cancer, Bergamo, April 2018, 164, (Supplement 1), 2018, pp200 - 200
Marchocki Z, Gleeson N, Abu Saadeh F, Ward MP, O'Toole SA, Norris LA, Fibrinogen, D-Dimers and thrombin generation assays as predictors of the risk of recurrent VTE in patients with gynaecological malignancies, Thrombosis Research, 164, (S1), 2018, pp200-
Thompson C, McCormick C, Kamran W, O'Riain C, Norris L, Gallagher D, Gleeson N., Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes, Irish Journal of Medical Science, 2018
Z. Marchocki, L.N. Norris, S.A. O'Toole, N. Gleeson, F. Abu Saadeh S235, Patients experience and compliance with extended LMWH prophylaxis post-surgery for gynaecological cancer, Thrombosis Research, International Congress on Thrombosis and Haemostasis Issues in Cancer, Bergamo, April 2018, 164, (Supplement 1), Elsevier, 2018, ppS235 - S235
Saadeh Feras Abu, Riain Ciaran O, Mc Cormack Ciara, Gleeson Noreen, Lung metastases from benign uterine leiomyoma: does 18-FDG-PET/CT have a role to play? , Irish Journal of Medical Science , 2018
Thompson C, Kamran W, Dockrell L , Khalid S, Kumari M, Ibrahim N, O'Leary J, Norris L, Petzold M, Abu Saadeh F, O'Toole S, Gleeson N., The clearance of Serum Human Epididymis Protein 4 following primary cytoreductive surgery for ovarian carcinoma, International J Gynaecol Cancer 2018; 28(6): 1066-72, 28, (6), 2018, p1066 - 1972
Ward MP, Abu Saadeh A, O'Leary JJ, Gleeson N, O'Toole SA, Norris LA, The effect of neoadjuvant chemotherapy on the activated protein C (aPC) pathway in high grade serous ovarian cancer patients, Research Practice in Thrombosis and Haemostasis , (S1), 2017, pp625-
Wong A, Anglim B, Wahab N, Gleeson N, A review of the open laparoscopic Hasson technique and retrieval of adnexal specimen via umbilicus, Journal of Obstetrics & Gynaecology , 37, (4), 2017, p487 - 491
Marchocki Z, Abu Saadeh F, Gleeson N, Norris L, Risk of recurrence of venous thromboembolism in patients with gynaecological cancer, Thrombosis Research, Womens Issues in Thrombosis and Haemostasis, Barcelona, March 2017, 151, (Supplement 1), 2017, ppS133 - S133
Karam A, Ledermann JA, Kim JW, Sehouli J, Lu K, Gourley C, Katsumata N, Burger RA, Nam BH, Bacon M, Ng C, Pfisterer J, Bekkers RLM, Casado Herráez A, Redondo A, Fujiwara H, Gleeson N, Rosengarten O, Scambia G, Zhu J, Okamoto A, Stuart G, Ochiai K, Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup:, Annals of Oncology, 2017, p711 - 717
Spillane C, Ffrench B, Cooney A, Ruttle C, Bogdanska A, Gleeson N, Abu Saadeh F, Kamran W, O'Riain C, Flavin R, Gallagher M, Martin C, Sheils O, O'Toole SA, O'Leary J., A digital pathway method to identify all forms of CTCs. , Lab Invest , 97, 2017, ppA463-
Maritschnegg E, Obermayr E, Holzer B, Gleeson N, Heitz F, Massuger L, Pristauz Telsnigg G, Rosenthal A, Trillsch F, Van Nieuwenhuysen E, Zikan M, Speiser P, Zeillinger R, Detection of a clinically occult ovarian carcinoma by new diagnostic tools., Clinical Cancer Research , Ovarian Cancer Symposium, Washington DC, 2017
Arts, Florence A and Keogh, Lisa and Smyth, Paul and O'Toole, Sharon and Ta, Robert and Gleeson, Noreen and O'Leary, John J and Flavin, Richard and Sheils, Orla, miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma, Human pathology, 70, 2017, p98 - 104
C. Spourquet, M.P. Ward, F.A. Saadeh, J.J. O'Leary, N. Gleeson, S.A. O'Toole, L.A. Norris., Expression of Coagulation Proteases from the Activated Protein C Pathway in Ovarian Tumours, Research Practice in Thrombosis and Haemostasis , ISTH, Berlin, July 2017, 1, (1), Wiley, 2017, pp630 - 630
Martin F, Long JC, O'Toole SA, O'Leary JJ, Abu Saadeh F, Gleeson N, Norris LA, . Tumour expression of coagulation proteases of the aPC pathway-a role in the pathogenesis of gynaecological cancers? , Thrombosis Research, 140 , (S1), 2016, ppS181-
Wahab NAA, Saadeh FA, Wong A, Gleeson N, Negative pressure wound treatment (NPWT) in vulva and groin wounds in gynaecologic oncology. , European journal of gynaecological oncology , 37 , (5 ), 2016, p632 - 637
Cooney A, Ffrench B, Spillane CD, Ruttle C, Gleeson N, O'Riain C, Flavin R, Gallagher MF, Martin C, Sheils O, O'Toole S, O'Leary J, Digital Multi-Colour CTC Detection, Laboratory Investigation, 96, (A511), A512, 2016
Petch S, Norris L, O'Toole S, Gleeson N, Abu Saadeh F., Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice, Thrombosis Research, 145, 2016, p126 - 128
Mahon S, McFadden J, Gleeson N, O Riain C, Would fallopian tube tissue be left behind? Quantitation of tubal-type epithelium within ovary at the time of risk reducing salpingo-oophorectomy - implications for ovary conserving strategies. , Modern Pathology , 29, (S2), 2016, pp296A-
Norris LA, Martin FA, O'Toole SA, Saadeh FA, Gleeson N. , Determinants of thrombin generation in gynaecological malignancies, Thrombosis Research , 140, (S1), 2016, ppS185-
DeMaio A, Rizmee S, Gleeson N, The Clavien-Dindo classification of surgical complications for procedures in gynaecological oncology, European J Obstet Gynecol Reprod Biol , 206, 2016, ppE31 - E32
Spillane C, Ffrench B, Cooney A, Ruttle C, Bogdanska A, Gleeson N, Abu Saadeh F, Kamran W, O'Riain C, Flavin R, Gallagher M, Martin C, Sheils O, O'Toole SA, O'Leary J, A novel digital pathology approach to definitively identify ovarian cancer CTCs, . International Journal of Gynaecological Cancer, 26, (3), 2016, pp796-
Martin F, Long JC, O'Toole SA, O'Leary JJ, Abu Saadeh F, Gleeson N, Norris LA, Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?, Thrombosis Research, International Congress on Thrombosis and Haemostasis Issues in Cancer, Bergamo, April 2016, 140, (Supplement 1), 2016, ppS181 - S181
Field K, Ryan MJ, Saadeh FA, Kamran W, Brennan V, Gillham C, Gleeson N, Selective arterial embolisation for intractable vaginal haemorrhage in genital tract malignancies , Eur J Gynaecol Oncol , 37 , (03 ), 2016, p736 - 740
Flynn A, Burke N, Byrne B, Gleeson N, Wynne B, Barnes L, Two case reports of generalized pustular psoriasis of pregnancy: Different outcomes , Obstetric Medicine , 9, (2), 2016, p55 - 59
Abu Saadeh, F, Langhe R, Galvin DM, O Toole SA, O'Donnell DM, Gleeson N, Norris LA, Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy. , Thrombosis Research, 139, 2016, p135 - 141
Abu Saadeh F , Galvin D, Alsharbaty M J, Gleeson N, Paravaginal aggressive angiomyxoma , British Medical Journal Case Reports, PMID:25833906, 2015
Langhe R, Norris L, Saadeh FA, Blackshields G, Varley R, Harrison A, Gleeson N, Spillane C, Martin C, O'Donnell DM, D'Arcy T, O'Leary J, O'Toole S, A novel serum microRNA panel to discriminate benign from malignant ovarian disease., Cancer letters, 356, (2 Pt B), 2015, p628-36
Gleeson LE, Varghese C, Kane M, McDonald C, Gleeson N, McLaughlin AM, Butler K, Gavin P, Keane J , Chronic tuberculous salpingitis followed by successful IVF conception and congenital tuberculosis, QJM- An International Journal of Medicine , 108, (11), 2015, p899 - 900
Maher N, Gleeson N, Darcy T, Byrne B, Comparison of blood transfusion and surgical complications in peripartum hysterectomy when anticipated and unanticipated, Journal of Obstetrics and Gynaecology , 36, (1), 2015, p1 - 4
Abu Saadeh F, Collins V, Al-Saadi M, Gleeson N, An Unusual Relapse of Acute Myeloid Leukaemia , British Medical Journal Case Reports, doi: 10.1136, 2015
Saadeh FA, Cheema I, McCormick P, Gleeson N, Co-Operative Radical Pelvic Surgery: A Role for the Gynecologist in Vaginal Reconstruction Using a Uterine Myoserosal Flap in Urological and Anorectal Cancer Surgery., International Journal of Gynecological Cancer, 25, (5), 2015, p931 - 936
Wahab NAA, Abu Saadeh F, Lavelle M, Gleeson N, Could sentinel node mapping of groin cause abdominal wall metastases in vulval cancer? , Gynecologic & Obstetrical Investigation , 79, 2015, p280 - 284
Rafee S, Elamin Y.Y, Joyce E, Toner M, Flavin R, McDermott R, Sheehy N, Hennessy B, O'Byrne K, Gleeson N, Osman N, Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement, Tumori, 101, (2), 2015, pe35 - e39
O Gorman C, Burke N, Norris L, Gleeson N, Abu Saadeh F, Reducing venous thromboembolic events associated with ovarian cancer: are we winning the battle? , Thrombosis Research , 135, 2015, ppS66-
Kamran MW, O'Toole F, Meghen K, Wahab AN , Abu Saadeh F, Gleeson N, Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan as combined PET-CT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulval cancer: A correlation with groin node metastasis , European Journal of Gynaecological Oncology, 35, (3), 2014, p230 - 235
Ibrahim N, Norris L, O'Toole S, Gleeson N, The effect of LMWH (tinzaparin) post surgery in gynaecological patients: a study of ant-Xa activity levels., Thrombosis Research, 7th Internation Conference on Thrombosis & Hemostatis Issues in Cancer,, Bergamo Italy, May 2014, edited by A Falanga, B. Brenner, F, Rickles , 133, (Suppl 2), Elsevier, 2014, pps204-
Wong LF, Wahab NA, Gleeson N, Appendectomy with cytoreductive surgery for ovarian and type 2 endometrial carcinoma., European journal of gynaecological oncology, 35, (2), 2014, p143-8
Wong LFA, Wahab NA, Gleeson N, Appendectomy with cytoreductive surgery for ovarian and type-2 endometrial cancers, European Journal of Gynaecological Oncology , 35, (2), 2014, p143 - 148
Durcan L, Gleeson N, McKiernan S, Cunnane G., A benign tumor as the apparent trigger for myopathy, J Clin Rheumatology , 20, (2), 2014, p115 - 117
Abu Saadeh F, O'Toole S, Gleeson N, Norris L, Peak ant-Xa levels following LMWH (tinzaparin) prophylaxis in gynaecological cancer patients post surgery, Thrombosis Research, 7th Internation Conference on Thrombosis & Hemostatis Issues in Cancer, , Bergamot Italy, May 2014, edited by A Falanga, B. Brenner, F, Rickles , 133, (Suppl 2), Elsevier, 2014
Abu Saadeh F, O'Toole S, Gleeson N, Norris L, Peak anti Xa levels following LMWH (tinzaparin) prophylaxis in gynaecological cancer patients post surgery, Thrombosis Research , 133 , (S2), 2014, ppS223-
Abu Saadeh Feras, Wahab Nor, Gleeson N, An unusual presentation of endometriosis, British Medical Journal Case Reports , doi:10.11/bcr-2014-2, 2014
Ibrahim. N, Norris. L, O'Toole. S, McHugh, T. Abu Saadeh. F, Gleeson. N. , Does the extended thromboprophylaxix help to reduce the incidence of venous thromboembolism in gynaecological cancer patients ?, THROMBOSIS RESEARCH, THROMBOSIS RESEARCH, 133, (S244), 2014
Ibrahim N, Norris L, Nikolov N, Gleeson N, Thromboelastography as a tool for detecting hypercoagulability in gynaecological cancer patients undergoing surgery, Thrombosis Research, 7th International Conference on Thrombosis & Hemostatis Issues in Cancer,, Bergamo Italy, May 2014, edited by A Falanga, B. Brenner, F, Rickles , 133, (Suppl 2), Elsevier, 2014
d'Adhemar CJ, Spillane CD, Gallagher MF, Bates M, Costello KM, Barry-O'Crowley J, Haley K, Kernan N, Murphy C, Smyth PC, O'Byrne K, Pennington S, Cooke AA, Ffrench B, Martin CM, O'Donnell D, Hennessy B, Stordal B, Finn S, McCann A, Gleeson N, D'Arcy T, Flood B, O'Neill LA, Sheils O, O'Toole S, O'Leary JJ., The MyD88+ Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer., PLoS One. , 9, (6), 2014, pe100816-
McKenny M, Conroy P, Wong A, Farren M, Gleeson N, Walsh C, O'Malley C, Dowd N, A randomised prospective trial of intra-operative oesophageal Doppler-guided fluid administration in major gynaecological surgery., Anaesthesia, 68, (12), 2013, p1224-31
Kamran MW, Wahab A, Gleeson N, Laparoscopic transposition of ovaries with extra-peritoneal tunelling , International Journal of Gynecological Cancer , 23, (8), 2013, ppS1-
O'Toole F, Meghen K, Nor Wahab A, Abu Saadeh F, Gleeson N, FDG PET-CT in pre-operative assessment of vulval carcinoma. A single institution's experience over four years., International Journal of Gynecological Cancer 2013; 23 (8), S1, 23, (8), 2013
Ibrahim N, Norris L, Nikolov N, Gleeson N, Detecting hypercoagulability in gynaecological cancer patients undergoing surgery - the role of thromboelastography, International Journal of Gynecological Cancer , 23, (8), 2013, ppS1-
Wong LF, Gleeson N, Myomectomy: a suturing technique for the open procedure., Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 33, (2), 2013, p197-8
Greimel E, Kristensen GB, van der Burg ME, Coronado P, Rustin G, del Rio AS, Reed NS, Nordal RR, Coens C, Vergote I, Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy., Gynecologic oncology, 131, (2), 2013, p437-44
Abu Saadeh, Norris L, O'Toole S, Mohamed BM, Langhe R, O'Leary J, Gleeson N, Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk., Thrombosis Research, 132, 2013, p627 - 634
Langhe R, Norris LA, Abu Saadeh F,Petzold M, Abu Saadeh F, Kamran W, Ibrahim N, Nassan M, Gleeson N, O'Leary JJ, O'Toole S., Roma index improves specificity of ovarian cancer diagnosis compared to CA125 alone, International Journal of Gynecological Cancer, 23, (8), 2013, ppS1-
Kamran WM, Ahmed S, Wong LFA, Vaughan DA, McVey RM, Gleeson N., Skin bridge loop stoma in a gynecologic oncology unit, Gynecologic Surgery , 29, (1), 2013, p47 - 51
Abu Saadeh F, Norris L, O'Toole F, Langhe R, Gleeson N, Does chemotherapy cause hypercoagulability in ovarian cancer patients? , International Journal of Gynecological Cancer , 23(8) , (S1), 2013
Abu Saadeh F, Cheema N, Gleeson N, Vaginal and vestibular reconstruction following radical cystectomy and urethrectomy: a new technique , International Journal of Gynecological Cancer 23(8) S1. , 23(8) , (S1), 2013
Abu Saadeh F, Norris L, O'Toole S, Gleeson N, Venous thromboembolism in ovarian cancer: Incidence, risk factors and impact on survival., European Journal of Obstetrics & Gynecology and Reproductive Biology , 170, (1), 2013, p214 - 218
Laios A, Mohamed B, Kelly L, Flavin R, Finn S, McEvoy L, Gallagher M, Martin C, Shiels O, Ring M, Davies A, Lawson M, Gleeson N, D'Arcy T, d'Adhemar C, Norris L, Langhe R, AbuSaadeh F, O'Leary J, O'Toole S., Pre-treatment of platinum resistant ovarian cancer cells with and MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening. , International Journal of Molecular Sciences., 14, (1), 2013, p2085 - 2103
Kamran MW, Vaughan D, Crosby D, Wahab NA, Saadeh FA, Gleeson N, Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC)., European journal of obstetrics, gynecology, and reproductive biology, 170, (1), 2013, p251-4
Kamran MW, Wong LFA, Ahmed S, Vaughan DA, McVey R, Gleeson N., Skin bridge loop stoma in a Gynecologic Oncology Unit, International Journal of Gynecological Cancer , 22, (10), 2012, ppS3-
Abu Saadeh F, Norris L, O'Toole S, Langhe R, Gleeson N., Procoagulant activity in patients with gynecological malignancies and the effect of neoadjuvant chemotherapy , Thrombosis Research, 6th International Conference on Thrombosis & Hemostasis Issues in Cancer, Bergamo Italy, April 2012, edited by A Falanga, B. Brenner, F, Rickles , 129, (Suppl 1), Elsevier, 2012
Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, Gleeson. N, Endogenous thrombin potential as a marker for venous thrombosis in ovarian cancer., International Journal of Gynecological Cancer , 14th Biennial Meeting of the International Gynecological Cancer Society., Vancouver, Canada, October 2012, 22, (Suppl 3), 2012, ppE248-
Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, O' Leary. J, Gleeson. N. , Why is venous thromboembolism is a common complication of ovarian cancer? , International Journal of Gynecological Cancer , 14th Biennial Meeting of the International Gynecological Cancer Society. , Vancouver, Canada, October 2012, 22, (Suppl 3), 2012, ppE247-
Abu Saadeh. F, Norris. L, O' Toole, Gleeson. N., Assessing the risk and mortality of venous thromboembolism in ovarian cancer., International Journal of Gynecological Cancer, 14th Biennial Meeting of the International Gynecological Cancer Society., Vancouver, Canada, October 2012, 22, (Suppl 3), 2012, ppE246-
Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, Gleeson. N., ETP as a marker for venous thromboembolism in gynaecologial cancer patients post surgery, International Journal of Gynecological Cancer, 14th Biennial Meeting of the International Gynecological Cancer Society., Vancouver, Canada, October 2012, 22, (Suppl 3), 2012, ppE249-
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Leary JJ, Gleeson N., Does tissue factor and tissue factor pathway inhibitor over-expression play a role in the development of venous thromboembolism in ovarian cancer patients?, Thrombosis Research, 6th International Conference on Thrombosis & Hemostasis Issues in Cancer, Bergamo Italy, April 2012, edited by A Falanga, B. Brenner, F, Rickles , 129, ((Suppl 1)), Elsevier, 2012, pp170-
) Kamran W, Abu Saadeh. F, Crosby D, Vaughan D, Gleeson. N. , Obstetrician gynaecologists' attitudes to salpingectomy in the prevention of tubo-ovarian cancer: a willingness to change, International Journal of Gynecological Cancer , Volume 22(10), (S3), 2012, ppE375-
Carroll PA, Nolan C, Clarke R, Farrell M, Gleeson N, Boyle T, Dunne B, Daly PA, Kennedy MJ, Connolly EM, Surgical management of an Irish cohort of BRCA-mutation carriers., Breast (Edinburgh, Scotland), 20, (5), 2011, p419-23
Flood K, Breathnach F, Gleeson N, An unusual presentation of a dermoid cyst., Journal of Obstetrics and Gynaecology , 30, (1), 2010, p72-3
Walsh DJ, Sills ES, Shkrobot LV, Gleeson NC, Sheppard MN, Walsh AP, Ovarian serous adenocarcinoma identified during IVF: diagnostic approach, surgical management, and reproductive outcome., World journal of surgical oncology, 7, 2009, p46
Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O' Leary J, Potential role of miR-9 and miR-223 in recurrent ovarian cancer., Molecular cancer, 7, 2008, p35
Laios A, O'Toole SA, Flavin R, Martin C, Ring M, Gleeson N, D'Arcy T, McGuinness EP, Sheils O, Sheppard BL, O' Leary JJ, An integrative model for recurrence in ovarian cancer., Molecular cancer, 7, 2008, p8
A Laios, SA O'Toole, B Sheppard, N Gleeson, T D'Arcy, E McGuinness, M Ring, R Flavin, C Martin, J O'Brien, D O'Connell, O Sheils, D Cahill, E Gaffney, JJ O'Leary, Recurrence in Ovarian Cancer; a Transcriptomic Approach, Laboratory Investigation, USCAP 96th Annual Meeting, San Diego, CA, March, 87, (S1), 2007, ppA204-
Tan EK, Difficult caesarean delivery of an impacted head and neonatal skull fracture: can the morbidity be avoided?, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 27, (4), 2007, p427-8
O'Toole SA, Laios A, Sheppard B, Gleeson N, D'Arcy T, McGuinness EPJ, Ring M, Gaffney M, Flavin R, Martin C, O'Brien J, O'Connell D, Sheils O, Cahill D and O'Leary JJ. , miRNA Signatures in Primary Versus Recurrent Ovarian Cancers, Laboratory Investigation , USCAP 96th Annual Meeting, San Diego, CA, March 2007, 87, (S1), 2007, ppA209-
Coughlan C, McAuliffe F, Bermingham N, Gleeson N, Vaginal cytology following primary hysterectomy for cervical cancer: is it useful?, Irish journal of medical science, 175, (1), 2006, p45-9
Laios A, O'Toole SA, Sheppard BL, Gleeson NC, D'Arcy T, McGuinness EPJ, Ring M, Sheils O and O'Leary JJ. , Molecular profiling of primary versus recurrent ovarian serous papillary adenocarcinomas. , Laboratory Investigation, United States and Canadian Society of Pathology, Atlanta, USA, Feb 2006, 86, (Suppl 1), Nature, 2006, pp185 - 185
SA O'Toole, A Laios, BL Sheppard, NC Gleeson, T D'Arcy, EPJ McGuinness, J Bonnar, O Sheils and JJ O'Leary. , Potential predictors of chemotherapy response in ovarian cancer how do we define chemosensitivity?, Laboratory Investigation, United States and Canadian Society of Pathology, Atlanta, USA, Feb 2006, 86, (Suppl 1), Nature, 2006, pp190A
Breathnach F, Daly S, Griffin E, Gleeson N, Intracervical application of synthetic hydrogel sealant for preterm prelabor rupture of membranes: a case report., Journal of perinatal medicine, 33, (5), 2005, p458-60
O'Toole SA, Sheppard BL, McGuinness EPJ, Gleeson NC, Bonnar J. , Predicting the response of gynaecological tumours to chemotherapy. , Cancer Research 2004; 24(2A):533-534., 24, (2A), 2004, pp533 - 534
Ononeze BO, Gleeson N, Turner MJ, Management of third degree perineal tear and choice of mode of delivery in subsequent pregnancies., Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 24, (2), 2004, p148-51
O'Toole SA, Sheppard BL, McGuinness EP, Gleeson NC, Yoneda M, Bonnar J, The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours., Cancer detection and prevention, 27, (1), 2003, p47-54
Local and regional recurrence of vulval cancer: management dilemmas in, editor(s)Best Practice & Research Clinical Obstetrics & Gynaecology 2003 , Best Practice & Research Clinical Obstetrics & Gynaecology , 2003, pp663 - 668, [Coulter J, Gleeson N.]
O'Toole SA, Sheppard Brian L, McGuinness EPJ, Gleeson NC, Misaho Yoneda, Bonnar J., Determining the response of gynaecological tumours to chemotherapy using an MTS cytotoxicity assay in combination with an explant culture technique ., British Journal of Cancer , 86, 2002
O'Toole SA, Sheppard BL, McGuinness E, Gleeson NC, Bonnar J, Serous papillary adenocarcinomas of the ovary display heterogeneity in their response to chemotherapy., International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 11, (5), 2001, p365-71
O'Toole S, Sheppard B.L., Bonnar J, McGuinness E, Gleeson N., Cell Culture drug sensitivity/resistance testing of malignant gynaecological tumours., British Journal of Obstetrics and Gynaecology , 107, (6), 2000, p818 - 819
Finan MA, Fiorica JV, Hoffman MS, Barton DP, Gleeson N, Roberts WS, Cavanagh D, Massive pelvic hemorrhage during gynecologic cancer surgery: "pack and go back"., Gynecologic oncology, 62, (3), 1996, p390-5
Gleeson N, Gough F, Barry Walsh C, Turner M, Clinch J, Prendiville W. , Large loop excision of the transformation zone (LLETZ) and LLETZ conisation in the management of early squamous carcinoma of the cervix., Journal of Obstetrics and Gynaecology , 16, 1996, p525 - 528
Gleeson NC, Hill BJ, Moscinski LC, Mark JE, Roberts WS, Hoffman MS, Fiorica JV, Cavanagh D, Urokinase plasminogen activator in ovarian cancer., European Journal of Gynaecological Oncology, 17, (2), 1996, p110-3
Hoffman MS, Fiorica JV, Gleeson NC, Roberts WS, Cavanagh D, A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease., Gynecologic oncology, 60, (2), 1996, p292-4
The management of vulval dystrophy in, editor(s)John Bonnar , Recent Advances in Obstetrics and Gynaecology Vol 19, Churchill Livingstone , 1995, pp185 - 194, [Noreen Gleeson]
Gleeson NC., Modification of the Cherney incision in gynaecological oncology surgery., British Journal of Obstetrics and Gynaecology , 102, 1995, p925 - 926
Gleeson NC, Mark JE, Roberts WS, Hoffman MS, Fiorica JV, Cavanagh D., Predictive value of combined assays of urinary gonadotropin peptide (UGP) and CA125 in ovarian cancer., Journal of Obstetrics and Gynaecology, 15, 1995, p328 - 332
Finan MA, Barton DP, Fiorica JV, Hoffman MS, Roberts WS, Gleeson N, Cavanagh D, Ileus following gynecologic surgery: management with water-soluble hyperosmolar radiocontrast material., Southern medical journal, 88, (5), 1995, p539-42
Gleeson NC., Cyclical changes in endometrial tissue plasminogen activator (t-PA) and plasminogen activator inhibitor - type 1 (PAI-1) in women with normal menstruation and essential menorrhagia., American Journal of Obstetrics & Gynecology , 171, 1994, p178 - 183
Finan MA, Fiorica JV, Roberts WS, Hoffman MS, Gleeson N, Barton DP, Cavanagh D, Artificial Dura Film for femoral vessel coverage after inguinofemoral lymphadenectomy., Gynecologic oncology, 55, (3 Pt 1), 1994, p333-5
Gleeson NC, Buggy F, Sheppard BL, Bonnar J, The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding., Acta obstetricia et gynecologica Scandinavica, 73, (3), 1994, p274-7
Gleeson N, Hoffman MS, Roberts WS, Ruffolo EH, Basal cell carcinoma of the vulva with groin node node metastases., Gynecologic oncology, 53, 1994, p366 - 368
Hoffman MS, Gleeson NC, Finan MA, Roberts WS, MS, Fiorica JV, Cavanagh D., Palliative intestinal surgery for patients with cancer of the cervix, Journal Gynecologic Surgery , 10, (2), 1994, p63 - 69
Gleeson N, Baile W, Roberts WS, Hoffman M, Fiorica JV, Barton D, Cavanagh D, Surgical and psychosexual outcome following vaginal reconstruction with pelvic exenteration., European journal of gynaecological oncology, 15, (2), 1994, p89-95
Hoffman MS, Lynch CM, Gleeson NC, Fiorica JV, Roberts WS, Cavanagh D, Colorectal anastomosis on a gynecologic oncology service., Gynecologic oncology, 55, (1), 1994, p60-5
Gleeson NC, Baile W, Roberts WS, Hoffman MS, Fiorica JV, Finan MA, Cavanagh D, Pudendal thigh fasciocutaneous flaps for vaginal reconstruction in gynecologic oncology., Gynecologic oncology, 54, (3), 1994, p269-74
Gleeson N, Gaffney EF, Gonsalves R, Quigley J, Bonnar J, Sarcomas of the female genital tract and pelvic soft tissues. A cluster of 14 cases in one year., Irish medical journal, 86, (6), 1994, p196-8
Gleeson NC, Parsons AK, Hoffman MS, Cavanagh D, Urinary ascites with pelvic urinoma presenting as ovarian neoplasm: clinical and ultrasonographic features., Obstetrics and gynecology, 82, (4 Pt 2 Suppl), 1993, p644-6
Gleeson N, Devitt M, Buggy F, Bonnar J, Menstrual blood loss measurement with gynaeseal., The Australian & New Zealand journal of obstetrics & gynaecology, 33, (1), 1993, p79-80
Barton DP, Hoffman MS, Roberts WS, Fiorica JV, Finan MA, Gleeson N, Cavanagh D, Use of local flaps in the preservation of fecal continence following resection of perianal neoplasias., International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 3, (5), 1993, p318-323
Gleeson N, Jordan M, Sheppard B, Bonnar J, Cyclical variation in endometrial oestrogen and progesterone receptors in women with normal menstruation and dysfunctional uterine bleeding., European journal of obstetrics, gynecology, and reproductive biology, 48, (3), 1993, p207-14
Fiorica JV, Gleeson N, Roberts WS, Hoffman MS, Barton DPJ, Cavanagh D. , Venous access in gynecologic oncology patients: A comparative study of two devices. , Surgical Forum , 1993, p526 - 529
Hoffman MS, Gleeson N, Diebel D, Roberts WS, Fiorica JV, Cavanagh D, Colostomy closure on a gynecologic oncology service., Gynecologic oncology, 49, (3), 1993, p299-302
Gleeson NC, Finan MA, Fiorica JV, Robert WS, Hoffman MS, Wilson J, Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid., European journal of gynaecological oncology, 14, (6), 1993, p461-5
Gleeson N, Gonsalves R, Bonnar J, Uterine fibrinolytic enzymes in endometrial cancer., European journal of gynaecological oncology, 14, (5), 1993, p369-73
Norris LA, Gleeson N, Sheppard BL, Bonnar J, Whole blood platelet aggregation in moderate and severe pre-eclampsia., British journal of obstetrics and gynaecology, 100, (7), 1993, p684-8
Finan MA, Hoffman MS, Fiorica JV, Roberts WS, Gleeson N, Barton DP, Cavanagh D, Surgical management of groin node metastases from nonvulvar gynecologic malignancies., Gynecologic oncology, 51, (2), 1993, p230-5
Gleeson N, Devitt M, Sheppard BL, Bonnar J, Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding., British journal of obstetrics and gynaecology, 100, (8), 1993, p768-71
Gleeson NC, Gonsalves R, Bonnar J, Plasminogen activator inhibitors in endometrial adenocarcinoma., Cancer, 72, (5), 1993, p1670-2
Gleeson NC, Fiorica JV, Mark JE, Pinelli DM, Hoffman MS, Roberts WS, Cavanagh D, Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients., Gynecologic oncology, 51, (3), 1993, p372-6
Gleeson NC, Gormally SM, Morrison JJ, O'Regan M, Instrumental rotational delivery in primiparae., Irish medical journal, 85, (4), 1992, p139-41
Gleeson N, Activators and Inhibitors of Fibrinolysis and Sex Steroid Receptors in the Endometrium in Dysfunctional Uterine Bleeding, Trinity College Dublin, 1992
Gleeson N, Gonsalves R, Bonnar J, The plasminogen activator urokinase and its inhibitor PAI-2 in endometrial cancer., Gynecologic oncology, 47, (1), 1992, p58-61
Gleeson N, Griffith A., The management of second stage of labour in primaparae with epidural analgesia., British Journal of Clinical Practice , 45, (2), 1991, p90 - 91
Gleeson N, Griffith A., The management of second stage of labour in primaparae with epidural analgesia. , British Journal of Clinical Practice , 45, (2), 1991, p90 - 91
Gleeson N, Gonsalves R, Bonnar J., Plasminogen activators in endometrial adenocarcinoma. , International Journal Gynaecological Cancer , 1, 1991, p223 - 226
Delayed maternal effort in the second stage of actively managed labour in primiparae with epidural analgesia. in, editor(s)F. Reynolds. , Epidural & Spinal Blockade in Obstetrics, Balliere Tindall , 1990, pp73 - 74, [Griffith AP, Gleeson N. ]
Sheppard BL, Boyle C, Gleeson N, Jordan M, Daly L, Bonnar J., Plasminogen activator inhibitors of the placenta and placental bed in normotensive and hypertensive pregnancy. , Placental Communications: biochemical, morphological and cellular aspects, 199, 1990, p151 - 159
Gleeson NC, Gaffney GM. , Ventrosuspension - five years of practice at the Rotunda Hospital reviewed. , Journal of Obstetrics and Gynaecology , 10, 1990, p415 - 418
Gleeson NC, Onwude JL, Uterine leiomyoma causing retained placenta., The British journal of clinical practice, 44, (12), 1990, p689-90
Non-Peer-Reviewed Publications
Wyrzykowska W, Norris L, Gleeson N, The risk of venous thrombosis following peri-operative blood transfusion in gynaecology and oncology patients, Junior Obstetrics & Gynaecology Society, Dublin, November 2018, 2018
Norris LA, Abu Saadeh F, Ward M, O'Toole SA, Marchocki Z, Ibrahim N, Gleeson N. , Development and validation of a risk model for prediction of venous thromboembolism in gynaecological cancer patients, 9th International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, Italy, April 2018,, 2018
Corbett G, Thompson C, Gleeson N, The curious case of a myometrial cyst / hydropic fibroid, Junior Obstetrics & Gynaecology Society, Dublin, Nov 2018, 2018
Marchocki Z, Norris LN, O'Toole SA, Gleeson N, Abu Saadeh F, Patients experience and compliance with extended LMWH prophylaxis post-surgery for gynaecological cancer, 9th International Conference on Thrombosis and Hemostasis Issues in Cancer., Bergamo, Italy, April 2018, 2018
Marchocki Z, Gleeson N, Abu Saadeh F, Ward MP, O'Toole SA, Norris LA. , Fibrinogen, D-Dimers and thrombin generation assays as predictors of the risk of recurrent VTE in patients with gynaecological malignancies, 9th International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, Italy, April 2018, 2018
Shahabuddin Y, O'Riain C, Gleeson N, Thompson C, Ovarian metastases from adenocarcinoma of cervix, Junior Obstetrics & Gynaecology Society, Dublin, Nov 2018, 2018
Ibrahim E, Gleeson N, Hyperthecosis in postmenopausal women, FIGO World Congress in Gynecology & Obstetrics, Rio de Janeiro, October 2018, 2018
White R, Thompson C, Maguire A, Gleeson N, A case of Synchronous Left Borderline Mucinous Tumour of the Ovary and Extra mammary Myofibroblastoma of the Abdominal Wall, Irish Congress of Obstetrics, Gynaecology & Perinatal Medicine., Kilkenny, December 2017, 2017
Marchocki Z, Abu Saadeh F, Norris L, Gleeson N. , Recurrence of venous thromboembolism in patients with gynaecological cancer - incidence and risk factors. , Fourth Irish Congress of Obstetrics, Gynaecology & Perinatal Medicine, Kilkenny, Ireland, December 2017, 2017
Kelly C, Thompson C, Abu Saadeh F, Gleeson N, Acute Kidney Injury Following Gynaecological Oncology Surgery: The Experience of an Irish Tertiary Centre. , European Society of Gynaecological Oncology Congress (ESGO), Vienna, November 2017 , 2017
Thompson C, Khalid A, O'Reagan C, Higgins A, Gleeson N., Total Parenteral Nutrition in Postoperative Care of Ovarian Cancer Patients Requiring Bowel Anastomosis: An Irish Gynaecological Oncology Experience, European Society of Gynaecological Oncology Congress (ESGO, Vienna, November 2017 , 2017
Thompson C, McCormick C, O Riain C, Kamran W, Gleeson N. , Risk reduction surgery in gynaecological oncology practice, RCOG World Congress, Cape Town, South Africa, March 2017, 2017
Field K, Ward M, O Connor H, Abu Saadeh F, Norris L, Gleeson N, Biomarkers in endometriosis, could miRNA offer a solution, World Congress of Endometriosis, Vancouver, September 2017, 2017
Spillane C, Ffrench B, Cooney A, Ruttle C, Bogdanska A, Gleeson N, Abu Saadeh F , Kamran W, O'Riain C, Flavin R, Gallagher M, Martin C, Sheils O, O'Toole S, O'Leary J., A digital pathway method to identify all forms of CTC, United States & Canadian Academy of Pathologists (USCAP, San Antonio, Texas, March 2017, 2017
O'Sullivan C, Thompson C, O'Riain C, Gleeson N, Androgen Secreting Juvenile Granulosa Cell Tumour., Irish Congress of Obstetrics, Gynaecology & Perinatal Medicine, Kilkenny, December 2017, 2017
) Field K, O Connor H,Ward M, Abu Saadeh F, Norris L, Gleeson N, Evaluating IL-6, MMP-2, and MMP-9 as biomarkers for endometriosis, Junior Obstetrics & Gynaecology Society, Four Provinces IOG, Dublin , Nov 2016, 2016
Power Foley M, Rizmee S, Norris L, Abu Saadeh F, Bogdanska A, Silva E, Ward M, Kamran W, Murphy C, Anglim M, Darcy T, Farah N, O Leary J, Gleeson N, O Toole S, Serum biomarker human epididymis protein 4 (HE4) as a supplemental triage tool in endometrial cancer , Junior Obstetrics & Gynaecology Society, Four Provinces IOG, Dublin, Nov 2016, 2016
) Maritschnegg E , Obermayr E, Holzer B, Gleeson N, Heitz F, Massuger L, Pristauz Telsnigg G, Rosenthal A, Trillsch F, Van Nieuwenhuysen E, Zikan M, Speiser P, Zeillinger R., Detection of a clinically occult ovarian carcinoma by new diagnostic tools , European Society of Gynaecologic Oncology, Lisbon, 2016, 2016
Foley MP, Shireen R, Norris L, Cullen M, Zainulabdin A, Long JC, McDonald S, Martin F, Cooney A, Ripollone S, Ibrahim N, Abu Saadeh F, Kamran W, Bogdanska A,Silva E, Ward M, Murphy C, Anglim M, D'Arcy T, Farah N, O'Connor H, O'Leary JJ, Gleeson N, O'Toole SA. , Is HE4 a sensitive biomarker for endometrial cancer?, Tenth International Cancer Conference, Trinity College Dublin , 2016, 2016
Spourquet C, Ward M, O'Leary J, Gleeson N, O'Toole S, Norris L, Expression of Coagulation Proteases from the activated Protein C Pathway in Ovarian Cancers, the Trinity College Dublin International Cancer Conference 2016, Dublin, 2016, 2016
McKendry K, Shireen R, Norris L, Long JC, Martin F, Ripollone S, Ibrahim N, Abu Saadeh F, Kamran W, D'Arcy T, O'Leary JJ, Gleeson N, O'Toole SA, HE4 Can Improve the Differentiation between Benign and Malignant Ovarian Masses. , Tenth International Cancer Conference, Trinity College Dublin , 2016, 2016
McDonald S, Thompson C, Gleeson N, Abu Saadeh F, Squamous carcinoma arising in a mature cystic teratoma, Junior Obstetrics & Gynaecology Society, Four Provinces IOG, Dublin, Nov 2016, 2016
Petch S, Norris LA, O'Toole SA, Gleeson N, Saadeh FA. , Peri-operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice, Thrombosis Research , 140, 2016, ppS173-
Field K, King K, Norris L,O Connor H,Gleeson N, Why the delay? A survey of women's experience s of reaching a diagnosis of endometriosis in Ireland. , Junior Obstetrics & Gynaecology Society, Four Provinces IOG, Dublin, Nov 2016, 2016
) McKendry K, Shireen R, Norris L, Long JC, Martin F, Ripollone S, Ibrahim N, Abu Saadeh F, Kamran W, D'Arcy T, O'Leary JJ, Gleeson N, O'Toole SA. , HE4 can improve the differentiation between benign and malignant ovarian masses, Irish Society of Gynaecological Oncology 2016, Dublin, Nov 2016, 2016
) McKendry K, Shireen R, Norris L, Long JC, Martin F, Ripollone S, Ibrahim N, Abu Saadeh F, Kamran W, D'Arcy T, O'Leary JJ, Gleeson N, O'Toole SA. , HE4 Can Improve the Differentiation between Benign and Malignant Ovarian Masses, Junior Obstetrics and Gynaecology Meeting, Dublin, 2016, 2016
Foley MP, Shireen R, Norris L, Cullen M, Zainulabdin A, Long JC, McDonald S, Martin F, Cooney A, Ripollone S, Ibrahim N, Abu Saadeh F, Kamran W, Bogdanska A,Silva E, Ward M, Murphy C, Anglim M, D'Arcy T, Farah N, O'Connor H, O'Leary JJ, Gleeson N, O'Toole SA. , Serum Biomarker Human Epididymis Protein 4 (HE4) - A supplemental triage tool in Endometrial Cancer? , Junior Obstetrics and Gynaecology Meeting, Dublin , 2016, 2016
Spourquet C, Ward M, O'Leary J, Gleeson N, O'Toole S, Norris L. , Expression of coagulation proteases and the activated Protein C pathway in ovarian cancers, Irish Society of Gynaecological Oncology , Dublin, Nov 2016, 2016
O'Toole SA, Shireen R, McDonald S, Norris L, Cooney A, AbuSaadeh F, Kamran W, Murphy C, Farah N, D'Arcy T, Gleeson N, O'Leary JJ. , HE4 has a role in treatment planning in endometrial cancer, Laboratory Investigation , 96, 2016, pp300A-
SA O'Toole, S Rizmee, S McDonald, L Norris, A Cooney, F Abu Saadeh, W Kamran, C Murphy, N Farah, T D'Arcy, N Gleeson, JJ O'Leary, Can HE4 guide treatment in endometrial cancer? , Irish Association for Cancer Research, Cork, 2016, 2016
Field K, Ward M, O Connor H, Abu Saadeh F, Norris L, Gleeson N, Biomarkers in endometriosis, could miRNA offer a solution, Junior Obstetrics & Gynaecology Society, Four Provinces IOG,, Dublin, Nov 2016, 2016
Foley MP, Shireen R, Norris L, Cullen M, Zainulabdin A, Long JC, McDonald S, Martin F, Cooney A, Ripollone S, Ibrahim N, Abu Saadeh F, Kamran W, Bogdanska A, Silva E, Ward M, Murphy C, Anglim M, D'Arcy T, Farah N, O'Connor H, O'Leary JJ, Gleeson N, O'Toole SA. , Applications of serum biomarker human epididymis protein 4 (HE4) in endometrial cancer. , Irish Society of Gynaecological Oncology , Dublin, Nov 2016, 2016
Mahon S, McFadden J, Mc Cormick C, Kamran W, Gleeson N, O Riain C, Would fallopian tube tissue be left behind? Quantitation of tubal-type epithelium within ovary at the time of risk reducing salpingo-oophorectomy - implications for ovary conserving strategies, United States & Canadian Academy of Pathology, Annual Meeting, Seattle, March 2016, 2016
C Spillane, B Ffrench, A Cooney, C Ruttle, A Bogdanska, N Gleeson, F Abu Saadeh, W Kamran, C O'Riain, R Flavin, M Gallagher, CM Martin, O Sheils, S O'Toole, JJ O'Leary, A novel digital pathology approach to definitively identify CTCs., 10th International Cancer Conference, Trinity College Dublin , 2016, 2016
) Martin F, Long JC, O'Toole S, O'Leary J, Gleeson N, Abu Saadeh F, and Norris L. , Expression of Coagulation Proteases from the activated Protein C Pathway in Gynaecological cancers, the Irish Association for Cancer Research annual meeting , Cork, 2016, 2016
Ward M, Manley O, O'Leary J, Gleeson N, Norris L, O'Toole S. , Expression of PP2A and a Humoral Immune Response to its Inhibitor, CIP2A, in Ovarian Cancer Patients, Irish Society of Gynaecological Oncology, Dublin , Nov 2016, 2016
Walsh J , Gascon-Perai K, Butler K, Langhe R, Hajar F, MAcauley C, Fauadi F, Norris L, Keogan M, Gleeson N, O'Leary J, O Toole S. , The role of radiology and biomarkers in triage of women presenting with a pelvic mass, Ovarian Cancer Forum of Ireland, Enniskillen, Northern Ireland, Sept 2015, 2015
) O Neill J, Nucci M, Niblett A, Sumathi V, Gleeson N, O' Riain C., High grade endometrial stromal sarcoma., to Irish Society of Surgical Pathology Annual Meeting, Belfast, 2015, 2015
Cooney A, Ffrench B, Gleeson N, O'Donnell D, Gallagher M, Spillane C, Ruttle C, O'Riain C, Flavin R, O Toole S, O'Leary JJ. , CTC-5: Isolation and identification of circulating tumour cells in ovarian cancer., Ovarian Cancer Forum of Ireland, Enniskillen, Northern Ireland, Sept 2015, 2015
Burke N, Aderemi J, O Riain C, D'Arcy T, Abu Saadeh F, Gleeson N, Endometrial cancer in extreme old age , Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
Connolly C, Gleeson N, Ó Riain C, What is in a name? One histological term describing two very different tumours, Irish Society of Surgical Pathology Annual Meeting, Belfast, 2015, 2015
) DeMaio A, Horan M, Rizmee S, Gleeson N, Primary retroperitoneal mucinous adenocarcinoma: a case report, Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
) Horan M, DeMaio A, Rizmee S, Gleeson N, Glassy cell carcinoma of the cervix, Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
Rizmee S, O Toole S, Kamran W, Abu Saadeh F, Gleeson N, Human epididymis protein 4 (HE4), a potential marker to distinguish atypical endometrial hyperplasia from endometrial carcinoma preoperatively, Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
Costigan D, Horan M, Knox M, Gleeson N, O'Riain C., An Unusual Aetiology of Apparent Recurrent Pelvic Tumour, Irish Society of Surgical Pathology Annual Meeting, Belfast, 2015, 2015
Walsh Jessica , Gascon-Perai K, Butler K, Langhe R, Norris L, Keogan M, Gleeson N, O'Leary J, O Toole S., Assessment of HE4 as an additional diagnostic tool to discriminate benign from malignant ovarian lesions, Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
McSharry E, O'Byrne L, Gleeson N,Abu Saadeh F Kamran W, Rizmee S., Three cases of large cystadenoma , Junior Obstetrics & Gynaecology Society, Four Provinces IOG, Dublin, Nov 2015, 2015
) O'Byrne L McSharry E, Rizmee S, Gleeson N, Kamran W, Abu Saadeh F, Tubal torsion, Junior Obstetrics & Gynaecology Society, Four Provinces IOG, Dublin, Nov 2015, 2015
Doyle R, O' Riain C, Barry R, Gleeson N, Gillham C, McMenamin M., Cutaneous metastases: the less likely primary, Irish Society of Surgical Pathology Annual Meeting, Belfast, 2015, 2015
DeMaio A, Horan M, Rizmee S, Gleeson N, Exotic histopathology presenting in a gynaecological setting , to Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
) Rizmee S, O Riain C, Gleeson N. , Glassy cell cancer of Cervix: a rare variant, European Society of Gynecological Oncology, Nice, France, Nov 2015, 2015
Connolly C, Gleeson N, O'Riain C , Undifferentiated endometrial carcinoma - an illustrative case report and discussion of an under-recognised aggressive tumour , Junior Obstetrics & Gynaecology Society, Four Provinces IOG, Dublin, Nov 2015, 2015
Walsh Jessica , Gascon-Perai K, Butler K, Langhe R, Norris L, Keogan M, Gleeson N, O'Leary J, O Toole S., Assessment of HE4 as an additional diagnostic tool to discriminate benign from malignant ovarian lesions, Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
Field K, Abu Saadeh F, Kamran W, Gillham C, Ryan M, Gleeson N. , Selective arterial embolization for massive vaginal haemorrhage in genital tract cancers, Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, May 2015, 2015
Galvin D, Collins V, Wahab NA, O'Riain C, Gleeson N, Abu Saadeh F, Paravaginal aggressive angiomyxoma, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
O'Gorman C, Burke N, Norris L, Gleeson N, Abu Saadeh F, Reducing venous thromboembolic events associated with ovarian cancer: Are we winning the battle, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Ibrahim N, Norris L, O'Toole S, Gleeson N, The effect of LMWH (tinzaparin) post surgery in gynaecological patients: a study of ant-Xa activity levels, 7th International Conference on Thrombosis & Hemostatis Issues in Cancer, Bergamo Italy, May 2014, 2014
Noreen Gleeson, Ovarian Cancer - a new pardigm, Northern Obstetrics and Gynaecology Society, Letterkenny, March, 2014
Collins V, NorWahab A, O'Riain C, Abu Saadeh F, Gleeson N. , Endometrial cancer 14 years after hysterectomy, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Ibrahim N, Norris L, Nikolov N, Gleeson N, Thromboelastography as a tool for detecting hypercoagulability in gynaecological cancer patients undergoing surgery, 7th International Conference on Thrombosis & Hemostatis Issues in Cancer, Bergamo Italy, May 2014, 2014
Ibrahim N, Norris L, O'Toole S, McHugh T, Gleeson N, Does extended thromboprophylaxis help reduce the incidence of venous thromboembolism in gynaecological cancer patients?, 7th International Conference on Thrombosis & Hemostatis Issues in Cancer, , Bergamo Italy, May 2014, 2014
McGoldrick A, O'Riain C, Darcy T, Gleeson N, Abu Saadeh F, Less radical surgery for cervical cancer: Is it necessary to remove parametrium in early stage cervical cancer (Stage IA2 & IB1), Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2014, 2014
Shireen R, O'Toole S, Abu Saadeh F, Kamran W, Gleeson N. , Human epididymis protein 4 (HE4) could discriminate complex atypical hyperplasia from endometrial cancer. , Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
McCormick C, Rizmee S, O'Riain C, Abu Saadeh F, Gleeson N, Kamran W, Risk reduction surgery (RRS) in gynaecological practice: A categorical analysis of indications and outcomes, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Galvin D, Collins V, Abu Saadeh F, Gleeson N. , Ovarian tumour & elevated AFP does not always equal yolk sac tumour, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Galvin D, Burke N, O'Riain C , Abu Saadeh F, Gleeson N, Generalised pustular psoriasis (GPP) in Pregnancy, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Noreen Gleeson, Peritoneal chemotherapy in ovarian cancer, All Ireland Ovarian Cancer Forum, Dublin, September, 2014
Burke N, O'Riain C, Darcy T, Abu Saadeh F, Gleeson N , Endometrial cancer in oldest age: Challenges & treatment approaches, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Field K, Norris L, Abu Saadeh F, Gleeson N. , MMPS and IL-6 as potential biomarkers for endometriosis , to Junior Obstetrics & Gynaecology Society ASM, Dublin , Nov 2014, 2014
McCormick C, Collins V, Iavanazzo C, O'Riain C, Kamran W, Gleeson N, Abu Saadeh F, Benign metastasising leiomyoma to the lung: A report of two cases, Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2014, 2014
) Petch S, Collins V, Norris L, Gleeson N, Abu Saadeh F, Extended venous thromboembolism (VTE) prophylaxis in gynaecological cancer surgery: A survey of current practice, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Abu Saadeh F, O'Toole S, Gleeson N, Norris L, Peak anti Xa levels following LMWH (tinzaparin) prophylaxis in gynaecological cancer patients post surgery., 7th International Conference on Thrombosis & Hemostatis Issues in Cancer, Bergamo Italy, May 2014, 2014
Ibrahim N, Norris L, O'Toole S, McHugh T, Gleeson N, Does extended thromboprophylaxis help reduce the incidence of venous thromboembolism in gynaecological cancer patients?, Thrombosis Research, 7th Internation Conference onal Thrombosis & Hemostatis Issues in Cancer,, Bergamo Italy, May 2014, edited by A Falanga, B. Brenner, F, Rickles , 133, (Suppl 2), Elsevier, 2014
Wong A, O'Toole S, Abu Saadeh F, Gleeson N. , Tissue factor inhibitor 2 (TFPI2) in clear cell cancer and benign ovarian tumours, Junior Obstetrics & Gynaecology Society ASM , Dublin, Nov 2014, 2014
Noreen Gleeson, Ovarian Cancer - or is it?, Northern Obstetrics and Gynaecology Society, Letterkenny, January, 2014
Langhe R, Norris , Abu Saadeh F,Petzold M, Abu Saadeh F, Kamran W, Ibrahim N, Nassan M, Gleeson N, O'Leary JJ, O'Toole S, Roma index improves specificity of ovarian cancer diagnosis compared to CA125 alone, European Society of Gynaecologic Oncology, Liverpool, Oct 2013, 2013
O'Toole F, Kamran W, Wahab NA, Abu Saadeh F, Gleeson N., Hybrid PE/CT in preoperative assessment of groin lymph nodes in squamous cancer of vulva, Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Langhe R, Norris L,Petzold M, Abu Saadeh F, Kamran W, Ibrahim N, Dockrell L, Khalid S, Naasan M, Gleeson N , O'Leary JJ, O'Toole S. , Development of a roma index for an "at risk" population improves the sensitivity and specificity of ovarian cancer diagnosis compared to CA125 alone, All Ireland Ovarian Cancer Forum, Dublin, Oct 2013, 2013
Langhe RI, O'Toole SA Norris LA, Harrison A, Varley R, AbuSaadeh F, Gleeson NC, Kamran W, O'Donnell D, O'Leary JJ. , Evaluation of HE4 and CA125 in ovarian cancer, IARC, Dublin, Feb 2013, 2013
Ibrahim N, Norris L, Nikolov N, Gleeson N, TEG as a measure of hypercoagulability in gynecoloigcal cancer patients undergoing surgery, British Gynaecological Cancer Society, Belfast, June 2013, 2013
Abu Saadeh F, Norris L, O'Toole F, Langhe R, Gleeson N, Does chemotherapy cause hypercoagulability in ovarian cancer patients? , European Society of Gynaecologic Oncology, Liverpool, Oct 2013, 2013
O'Toole F, Meghen K, Nor Wahab A, Abu Saadeh F, Gleeson N, FDG PET-CT in pre-operative assessment of vulval carcinoma. A single instituution's experience over four years., European Society of Gynaecologic Oncology, Liverpool, Oct 2013, 2013
Walsh J, Gascon-Perai K, Butler K, Gleeson N, O'Toole S, Assessment of HE4 as an additional diagnostic tool to discriminate benign and malignant ovarian lesions in patients presenting with a pelvic mass. , Junior Obstetrics & Gynaecology Society ASM, Dublin , Nov 2013, 2013
Langhe R, Norris L, Abu Saadeh F, Blackshields G, Varley R, Harrison A, Gleeson , Spillane C, Martin C, O'Donnell D, D'Arcy T, O'Toole S, O'Leary J., A novel serum microRNA panel to discriminate benign from malignant ovarian disease. , Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Noreen Gleeson, Ovarian cancer - the surgical pathway, Symposium on Gynaecological Cancers for Pharmaceutical Industry, Dublin, March , 2013
Meghen K, O'Toole F, Wahab NA, Kamran W, Gleeson N, AbuSaadeh F., Negative predictive value of PET-CT nodal status in women with operable cervix cancer, British Gynaecological Cancer Society, Belfast, June 2013, 2013
O'Toole F, Field K, Gleeson N., Case report: Endometriosis in the inguinal ligament, Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Ibrahim N, Norris L, Nikolov N, Gleeson N, Detecting hypercoagulability in gynaecological cancer patients undergoing surgery - the role of thromboelastography, European Society of Gynaecological Oncology, Liverpool, Oct 2013, 2013
Abdul Wahab N, Abu Saadeh F, Lavelle M, Gleeson N, Could sentinel node mapping of groin lymph nodes cause extranodal metastases in vulva cancer? , European Society of Gynaecological Oncology, Liverpool, Oct 2013, 2013
Anglim B, Wahab A, McSweeney A, Abu Saadeh F, Gleeson N. , D-dimers in ovarian cancer - a correlation with stage of disease, All Ireland Ovarian Cancer Forum, Dublin, Sept 2013, 2013
Ibrahim N, Norris L, O'Toole S, Gleeson N., Venous thromboembolism in gynaeoncology patients post surgery - is tinzaparin prophylaxis an effective anticoagulant? , ISPOR, Oct 2013, 2013
Wong LFA, Wahab NA Gleeson N., Appendectomy with cytoreductive surgery for ovarian and type 2 endometrial carcinoma, Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Ibrahim N, Norris L, O'Toole S, Gleeson N, Venous thromboembolism in gynae-oncology patients post surgery.Is tinzaparin prophylaxis an effective anticoagulant?, Value in Health , 16, (7), 2013, ppA513 - A514
Ibrahim N, Norris L, O'Toole S, Gleeson N., Is tinzaparin prophylaxis effective in gynaeoncology patients post surgery? , Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Abu Saadeh F, Norris L, O'Toole S, Langhe R, McEvoy L, O'Leary JJ, Gleeson N. , Pathogenesis and clinical significance of venous thrombosis in ovarian cancer, All Ireland Ovarian Cancer Forum, Dublin, Sept 2013, 2013
Kamran MW, Wahab A, Gleeson N, Laparoscopic transposition of ovaries with extra-peritoneal tunneling , European Society of Gynaecological Oncology, Liverpool, Oct 2013, 2013
Wong LFA, O'Toole S, Norris L, Gleeson N., Tissue factor inhibitor 2 (TFPI-2) as a marker for clear cell cancer , Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
O'Malley E, Wahab NA, Abu Saadeh F, Gleeson N, Peritoneal tuberculosis masquerading as advanced ovarian cancer: A case report. , All Ireland Ovarian Cancer Forum, Dublin, Sept 2013, 2013
Field K, O'Toole F, Wahab NA, Abu Saadeh F, Gleeson N., The Hasson technique - a video , Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Langhe R, O'Toole S, Norris L, Abu Saadeh F, Harrison A, Varley R, Kamran W, Naasssan M, Petzold M, Gleeson , O'Donnell D, O'Leary J., HE4 improves specificity of ovarian cancer detection, British Gynaecological Society Annual Scientific Meeting, Belfast, June 2013, 2013
Abdul Wahab N, Abu Saadeh F, Lavelle M, Gleeson N, Could sentinel node mapping of groin lymph nodes cause extranodal metastases in vulva cancer? , International Journal of Gynecological Cancer , 23, (8S), 2013, pp1-
) Ibrahim N, Norris L, Nikolov N, Gleeson N. , The role of thromboelastography in detecting hypercoagulability in ovarian cancer patients undergoing surgery. , All Ireland Ovarian Cancer Forum, Dublin, Sept 2013, 2013
Noreen Gleeson, Enhanced recovery in gyanecological oncology, Society of Pelvic Surgeons, Dusseldorf, June , 2013
Noreen Gleeson, BRCA mutations - relevance for the clinical gynaecologist, Consultants' Conference in Obstetrics & Gynaecology Royal College of Physicians, , Dublin, January, 2013
O'Toole F, Field K, Kamran W, Wahab NA, Abu Saadeh F, Gleeson N., Laparoscopic bilateral salpingoophorectomy - a demonstration of risk reduction surgery for the general gynaecologist, Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
) Abu Saadeh F, Norris L, O'Toole S, Langhe R, Gleeson N, Does chemotherapy cause hypercoagulability in ovarian cancer patients, British Gynaecological Cancer Society, Belfast, June 2013, 2013
Meghan K, O'Toole F, Nor Wahab A, Kamran W, Gleeson N, Abu Saadeh F, Negative predictive value of PET-CT nodal status in women with operable cervix cancer. , International Journal of Gynecological Cancer, 23(8) , 2013
Meghan K, O'Toole F, Nor Wahab A, Kamran W, Gleeson N, Abu Saadeh F, Negative predictive value of PET-CT nodal status in women with operable cervix cancer, European Society of Gynaecologic Oncology, Liverpool, Oct 2013, 2013
Anglim B, Wahab NA, McSweeney A, AbuSaadeh F, Norris L, Gleeson N, D-Dimers in gynaecological cancers, British Gynaecological Cancer Society, Belfast, June 2013, 2013
O'Toole F, Meghen K, Wahab NA, AbuSaadeh F, Gleeson N, FDG PET-CT in pre-operative assessment of vulval carcinoma, British Gynaecological Cancer Society, Belfast, June 2013, 2013
Field K, Kamran W, Wahab NA, Abu Saadeh F, Gleeson N., Embolization via transarterial catheter in the prevention and control of massive pelvic haemorrhage: a story of success in a gynaecological unit , Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Noreen Gleeson, Predicting venous thrombosis in gynaecologial cancers, National VTE in cancer symposium, Dublin, April, 2013
Ni Mhurchu M, O'Toole F, Gleeson N., Is routine MSU useful prior to surgery for genital tract cancers?, Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
O'Malley E, Abu Saadeh F, Wahab NA, Gleeson N., Diverse presentation of tuberculosis in obstetrics and gynaecology , Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2013, 2013
Abu Saadeh F, Cheema N, Gleeson N, Vaginal and vestibular reconstruction following radical cystectomy and urethrectomy: a new technique , European Society of Gynaecological Oncology, Liverpool, Oct 2013, 2013
Noreen Gleeson, Surgery without margins in gynecological oncology 2nd Irish Congress of Obstetrics, Gynaecology & Perinatal Medicine, nd Irish Congress of Obstetrics, Gynaecology & Perinatal Medicine, November 2012, November , 2012, Institute of Obstetricians & Gynaecologists
Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, O' Leary. J, Gleeson. N., Why is venous thromboembolism is a common complication of ovarian cancer?, 14th Biennial Meeting of the International Gynecological Cancer Society, Vancouver, Oct 2012, 2012
Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, Gleeson. N. , Endogenous thrombin potential as a marker for venous thrombosis in ovarian cancer, 14th Biennial Meeting of the International Gynecological Cancer Society, Vancouver, Canada, Oct 2012, 2012
Noreen Gleeson, , Ovarian Cancer Patient Day / Ovacare - Ovarian Cancer |Awareness & Patient Support Group, Dublin, October, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Leary JJ, Gleeson N., Does tissue factor and tissue factor pathway inhibitor over-expression play a role in the development of venous thromboembolism in ovarian cancer patients?, 6th International Conference on Thrombosis & Hemostasis Issues in Cancer, Bergamo Italy, April 2012, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Leary J, Gleeson N., The effects of chemotherapy on procoagulant activity in ovarian cancer patients, 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Kamran MW, Gleeson N, Laparoscopic transposition of ovary in the extraperitoneal space: Video , 14th Biennial Meeting of the International Gynecological Cancer Society, Vancouver, Canada, Oct 2012, 2012
Abu Saadeh F, Vaughan D, Gleeson N., Venous thromboembolism in Gynaecological Oncology. Clinical Education Programme, Hospital Doctor of Ireland, 18, (6), 2012, p7 - 11
Wong LFA, Crosby D, Ennis L, Kamran MW, Gleeson N., Vacuum assisted closure of wounds after failed conventional therapy in gynaecological cancer surgery., British Gynaecological Cancer Society, London, July 2012, 2012
) Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, Gleeson. N. , ETP as a marker for venous thromboembolism in gynaecological cancer patients post surgery, 14th Biennial Meeting of the International Gynecological Cancer Society, Vancouver, Canada, Oct 2012, 2012
Noreen Gleeson, The origins of ovarian cancer - a new paradigm, Grand rounds, St. James's Hospital, Dublin, November , 2012
Noreen Gleeson, Surgery without margins in gynecological oncology, 2nd Irish Congress of Obstetrics, Gynaecology & Perinatal Medicine, Dublin, November, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, Gleeson N., Procoagulant activity in patients with gynecological malignancies and the effect of neoadjuvant chemotherapy , 6th International Conference on Thrombosis & Hemostasis Issues in Cancer, Bergamo Italy, April 2012, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Malley E, McEvoy, Gleeson N., Endogenous thrombin potential and microparticles as procoagulant markers in gynaecological cancers., Irish Association for Cancer Research, Belfast, March 2012, 2012
Langhe B, O'Toole S, Norris L, Harrison A, Varley R, AbuSaadeh F, Kamran W, Gleeson N, O'Donnell D, O'Leary JJ, Diagnostic and prognostic potential of HE4 in ovarian cancer , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Anglim B, Khalid S, Wong A, Wahab NA, Tchrakian N, Gleeson N., Leydig cell tumour of ovary , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Wong A, Gleeson N., Myomectomy - a suturing technique for the open procedure, 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Anglim B ,Wong A, Khalid S, Wahab NA, Gleeson N., Pilot study of open laparoscopic Hasson technique and retrieval of specimen via umbilicus, 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Noreen Gleeson, Predicting venous thrombosis in gynaecological cancer patients , Haematology Symposium i, National Maternity Hospital, Dublin, September, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Malley E, McEvoy, Gleeson N., Procoagulant activity profile in gynaecological cancer patients post surgery, Irish Association for Cancer Research, Belfast, March 2012, 2012
Langhe R, O'Toole S, Norris L, Gleeson N, Darcy T, O'Donnell D, Abu Saadeh F, McEvoy L, Shiels O, O'Leary J, MicroRNA profiling in ovarian cancer, International Journal of Gynecological Cancer , 22, (8), 2012, ppE397-
Wong A, Crosby D, Ennis L, Wahab NA, Kamran W, Gleeson N, Vacuum assisted closure of complicated gynaecological oncology wounds, 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Anglim B, Wahab NA, McSweeney A, AbuSaadeh F, Kamran W, Gleeson N, D-Dimer - A biomarker in gynaecological cancers , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Noreen Gleeson, Surgical perspectives in ovarian cancer management Symposium on Ovarian Cancer, Dublin. May 2012 , Symposium on Ovarian Cancer, Dublin , May , 2012
Ferguson D, McCormick C, Gleeson N., Chronic vulval and perineal pain. A case of mosaic neurofibromatosis type 1. , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Malley E, McEvoy, Gleeson N., Endogenous thrombin potential and microparticles as procoagulant markers in gynaecological cancers., British Gynaecological Cancer Society, London, July 2012, 2012
Byrne D, Horan Maebh, Arigan M, Madhavan P, Gleeson N, A case report on ovarian clear cell carcinoma involving the abdominal aorta treated with aortic replacement. , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Nov 2012, 2012
Kamran MW, Wong LFA, Ahmed S, Vaughan DA, McVey R, Gleeson N., Skin bridge loop stoma in a Gynecologic Oncology Unit, 14th Biennial Meeting of the International Gynecological Cancer Society, Vancouver, Oct 2012, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Leary J, Gleeson N, Ovarian cancer - A study of risk, pathogenesis and clinical significance of venous thrombosis , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, Gleeson N., Postoperative procoagulant activity profile in gynaecological cancer patients. , British Gynaecological Cancer Society, London, July 2012, 2012
KamranMW, Vaughan D, Ahmed S, Abu Saadeh F, Crosby D, Gleeson N., Elective salpingectomy in the prevention of tubo-ovarian cancer, British Gynaecological Cancer Society, London, July 2012, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Malley E, McEvoy, Gleeson N., Expression of tissue factor, tissue factor pathway inhibitor and VEGF in ovarian cancer: correlation with venous thromboembolism, Irish Association for Cancer Research, Belfast, March 2012, 2012
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Leary J, Gleeson N., Expression of tissue factor, tissue factor inhibitor and VEGF in clear cell ovarian carcinoma: correlation with venous thromboembolism, British Gynaecological Cancer Society, London, July 2012, 2012
Kamran MW, Vaughan D, Abu Saadeh F, Crosby D, Gleeson N., Obstetrician/Gynaecologists attitudes to salpingectomy in prevention of tubo-ovarian cancer: A willingness to change, 14th Biennial Meeting of the International Gynecological Cancer Society, Vancouver, Oct 2012, 2012
Abu Saadeh. F, Norris. L, O' Toole, Gleeson. N., Assessing the risk and mortality of venous thromboembolism in ovarian cancer., 14th Biennial Meeting of the International Gynecological Cancer Society, Vancouver, Canada, Oct 2012, 2012
Wahab NA, Anglim B, McCormick, Abu Saadeh F, Gleeson N., Platelet lymphocyte ration: A marker of advanced disease in gynaecological cancer , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Vaughan D, Crosby D, Kamran W, Gleeson N., Opportunistic and interventional salpingectomy in women at risk - a strategy for preventing pelvic serous cancer (PSC). , 2nd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine, Wicklow, Nov 2012, 2012
Abu Saadeh F, Vaughan D, Gleeson N., Venous thromboembolism in Gynaecological Oncology. Clinical Education Programme, 2012, - 7-11
Abu Saadeh.F, O'Brien.Y, Gleeson.N, Are we over treating early stage cervical cancer? Management of cervical cancer stage 1A1 in CWIUH 2005 to 2010 , International Journal of Gynecological Cancer , 21, (S3), 2011
Abu Saadeh F, Norris L, O'Toole S, O'Leary JJ, Gleeson N., The role of tissue factor, tissue factor pathway inhibitor in ovarian cancer., 4th International Symposium on Women's Health Issues in Thrombosis & Haemostasis (WHITH). , Berlin, Feb 2011, 2011
Wong LFA, Gleeson N., Appendicectomy in staging of ovarian cancers , Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecolog, Dublin, Nov 2011, 2011
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Leary JJ, Gleeson N.., The role of tissue factor, TFPI and VEGF in ovarian cancer, Irish Gynaecological Oncology Society, Galway, April 2011, 2011
Almshwt M, Gleeson N., Ten year review of pelvic exenteration at St James's Hospital , Irish Gynaecological Oncology Society, Galway, April 2011, 2011
Abu Saadeh F, Norris L, O'Toole S, Langhe S, O'Leary JJ, Gleeson N.., The role of tissue factor, tissue factor pathway inhibitor in ovarian cancer., 9th International Scientific Meeting of the Royal College of Obstetricians & Gynaecologists. , Athens, Sept 2011, 2011
Channappa C, Wong LFA, Kamran W, Wahab AN, Gleeson N., Massive cervical fibroid - a surgical challenge , Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecology, Dublin, Nov 2011, 2011
Abu Saadeh F, Norris L, O'Toole S, Langhe R, O'Leary JJ, Gleeson N., The role of tissue factor, tissue factor pathway inhibitor and VEGF in ovarian cancer, the 17th International Meeting of the European Society of Gynecological Oncology , Milan, Sept 2011, 2011
Mullers S, Gleeson N., Complex atypical hyperplasia - can we predict progression to invasive disease? , Irish Gynaecological Oncology Society, Galway, April 2011, 2011
Laois A, Bashir M, Flavin R, Kelly L, Davies T, Ring M, Gleeson N, D'Arcy T, O'Leary JJ, O'Toole S, Revisiting the role of metalloproteeinases in ovarian cancer., Irish Gynaecological Oncology Society, Galway, April 2011, 2011
Wong LFA, Astbury K, Bates K, Broderick V, Gillham C, Gaffney E, Keogan M, Gleeson N , False positive PET/CT in leiomyosarcoma , Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecology, Dublin, Nov 2011, 2011
McVey R, Gleeson N, Towards an integrated national gynaecological oncological service: and urgency for change, Irish Society of Gynaecological Oncology, Galway, April 2011, 2011
Wong A, Gleeson N, Myomectomy - a modified suturing technique for the open procedure, Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecology, Dublin, Nov 2011, 2011
Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, O' Leary. J, Gleeson. N. , Expression of tissue factor, tissue factor pathway inhibitor and VEGF in clear cell ovarian carcinoma; correlation with venous thromboembolism. , 8th International Cancer Conference -State of the Art Cancer Care, Trinity College Dublin , Sept 2011, 2011
O'Brien Y, O,Neill A, Gleeson N, Cardiac failure post caesarean section, Obstetrics Divison of Royal Irish Academy of Medicine, Dublin, April 2011, 2011
Abu Saadeh. F, Norris. L, O' Toole. S, O' Leary. J, Gleeson. N. , The Role of Tissue Factor and Tissue Factor Pathway Inhibitor in Ovarian Cancer, Thrombosis Research ., 127, (S3), 2011, pp149-
McVey R, Gleeson N, Skin bridge loop colostomy in gynaecological oncology, Irish Gynaecological Oncology Society, Galway, April 2011, 2011
Wong LFA, Crosby D, Gleeson N., The use of vacuum assisted closure in complicated gynaecological wounds, Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecology, Dublin, Nov 2011, 2011
) Farren M, McVey R, Kamran W, Gleeson N., Tuberculosis and secondary infertility, Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecology, Dublin, Nov 2011, 2011
Abu Saadeh. F, Norris. L, O' Toole. S, Langhe. R, O' Leary. J, Gleeson. N. , The role of tissue factor and tissue factor pathway inhibitor and VEGF in ovarian cancer, International Journal of Gynaecological Cancer , 21 S3, 2011
Crosby D, Wong A, Chappana C, Wahab A, Kamran W, Gleeson N., Paraneoplastic necrotizing myopathy secondary to leiomyoma: case report, Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecology, Dublin, Nov 2011, 2011
Langhe R, O'Toole SA, Norris LA, Gleeson NC, D'Arcy T, Astbury K, O'Donnell D, AbuSaadeh F, McEvoy LM, Martin C, Sheils O, O'Leary JJ. , MicroRNA profiling in ovarian cancer, 8th International Cancer Conference -State of the Art Cancer Care, Trinity College Dublin , 2011, 2011
O'Malley E, Wong LFA, Cotter M, Gaffney E, O'Donnell D, Gillham C, Kamran W, Gleeson N, Adenoma Malignum of the cervix: a rare variant of cervical adenocarcinoma, Junior Obstetrics & Gynaecology Society/ Institute of Obstetrics & Gynaecology, Dublin, Nov 2011, 2011
Mullers S, Gleeson N., Complex atypical hyperplasia - can we predict progression to invasive disease? , Irish Gynaecological Oncology Society, Galway, April 2011, 2011
O'Brien Y, O,Neill A, Abu Saadeh F, Gleeson N, Peripartum cardiomyopathy, Junior Obstetrics & Gynaecology Society, Dublin, Nov 2010, 2010
O'Brien Y, Summerhill N, Milner M, Gleeson N , Uterine PECOMA, Junior Obstetrics & Gynaecology Society, Dublin , Nov 2010, 2010
Higgins A, Almshwt M, Abu Saadeh F, Gleeson N , An unusual location of a common cyst, Junior Obstetrics & Gynaecology Society, Dublin, Nov 2010, 2010
Maher M, O'Brien Y, Milner M, Gleeson N, Lymphoma - the great masquerader , Junior Obstetrics & Gynaecology Society, Dublin , Nov 2010, 2010
Mullers S, Gleeson N., Complex atypical hyperplasia - can we predict progression to invasive disease? , Junior Obstetrics & Gynaecology Society ASM, Dublin, Nov 2010, 2010
O'Brien Y, Abu Saadeh F, O'Donnell D, Gleeson N, Paraneoplastic sensory neuropathy in ovarian cancer , Junior Obstetrics & Gynaecology Society, Dublin, Nov 2010, 2010
Laios A, O'Toole SA, Flavin R, Martin C, Sheppard BL, Gleeson NC, D'Arcy T, McGuinness EPJ, Ring M, Sheils O, O'Leary JJ., An Integrative Transcriptome Map of Recurrence in Ovarian Cancer., PathSoc Conference, Oxford , Jan 2008, 2008
Laios A, O'Toole SA, Flavin R, Martin C, Sheppard BL, Gleeson NC, D'Arcy T, McGuinness EPJ, Ring M, Sheils O, O'Leary JJ, Altered Expression of miR-223 and miR-9 in Recurrent Ovarian Cancers may target the FGF Family. , PathSoc Conference, oxford, Jan 2008, 2008
D'Arcy T, Gleeson N, Astbury K, Duignan A, McKnight D., An evaluation of cervical cancer trends, British Society for Colposcopy & Cervical Pathology, Annual Scientific Meeting, Bermingham, April 2008, 2008
A Laios, SA O'Toole, B Png, R Flavin, L Kelly, T D'Arcy, E McGuinness, N Gleeson, B Sheppard, O Sheils, JJ O'Leary, Evaluation of mmp-9 inhibitor and cisplatin cytotoxicity in chemoresistant ovarian cancer cell line using high content screening (hcs) cell-based assays, Junior Obstetrics & Gynaecology Society, Dublin, Nov 2008, 2008
Jayaram A, Gaughan E, Darcy T, O'Connell M, Hollywood D, Gleeson N, Kennedy MJ, O'Donnell DM, Squamous carcinoma of the cervix in pregnancy - a therapeutic dilemma, European Academy of Gynaecological Cancer - ESO, Budapest, Nov 2008, 2008
Laios A, O'Toole SA, Flavin R, Kelly L, Sheppard B, Martin C, Ring M, D'Arcy T, McGuinness E, Gleeson N, Sheils O, O'Leary JJ., Dysregulation of miR-223 and miR-9 in recurrent ovarian cancer., Irish Association for Cancer Research, March 2008, 2008
Laios A, SA O'Toole, R Flavin, L Kelly, C Martin, M Ring, T D'Arcy, E McGuinness, N Gleeson, B Sheppard, O Sheils, JJ O'Leary., MicroRNAs and Recurrent Ovarian Cancer, Junior Obstetrics & Gynaecology Society, Dublin , Nov 2007, 2007
Laios A, O'Toole SA, Flavin R, Martin C, Sheppard BL, Gleeson NC, D'Arcy T, McGuinness EPJ, Ring M, Sheils O, O'Leary JJ., microRNA signatures in recurrent ovarian cancer, European Society of Gynaecological Oncology ESGO , Berlin, Sept 2007, 2007
) Laios A, O'Toole SA, Sheppard BL, Gleeson NC, D'Arcy T, McGuinness EPJ, Ring M, Smyth P, Martin C, Sheils O, O'Leary JJ., cDNA and miRNA signatures in recurrent ovarian cancer: evidence of overlap. , Irish Association for Cancer Research, Cork, March 2007, 2007
O'Toole S, Laois A, Sheppard BL, Gleeson N, D'Arcy T, McGuinness EPJ, Bonnar J, Sheils O, O'Leary JJ., Potential predictors of chemotherapy response in ovarian cancers., United States & Canadian Academy of Pathologists (USCAP, Feb 2006, 2006
O'Toole SA, Laios A, Sheppard BL, Gleeson NC, D'Arcy T, Mc Guinness EPJ, Ring M, Martin C, Flavin R, Cahill D, O'Brien J, Sheils O, O'Leary JJ., MiRNA signatures in primary versus recurrent ovarian cancers, Irish Gynaecological Oncology Society, Dublin, Oct 2006, 2006
) Araibi A, Abdulaziz A, Butt Hajeera, Duignan A, Gleeson N, Borderline Ovarian Cancers - Can we predict recurrence?, Irish Society of Gynaecological Oncology, Dublin, Oct 2006, 2006
Laios A, O'Toole SA, Sheppard BL, Gleeson NC, D'Arcy T, Mc Guinness EPJ, Ring M, Sheils O, O'Leary JJ., cDNA signatures in recurrent ovarian cancer, Irish Gynaecological Oncology Society, Dublin, Oct 2006, 2006
Butt Hajeera, Astbury K, O'Leary JJ, Gleeson N, Fetal triploidy and eclampsia, Irish Gynaecological Oncology Society, Dublin, Oct 2006, 2006
A Laios, SA O'Toole, B Sheppard, N Gleeson, T D'Arcy, E PJ McGuinness, M Ring, O Sheils and JJ O'Leary., Recurrent ovarian cancer; potential chemoresistant signatures, Junior Obstetrics & Gynaecology Society, Dublin, Nov 2006, 2006
Laios A, O'Toole SA, Sheppard BL, Gleeson NC, D'Arcy T, McGuinness EPJ, Ring M, Sheils O, Smyth P, O'Leary JJ. , Recurrent ovarian cancer cDNA signatures, Centenary Meeting of the Pathological Society of Great Britain and Ireland, Manchester, 2006, 2006
A Laios, SA O'Toole, B Sheppard, N Gleeson, T D'Arcy, E PJ McGuinness, M Ring, O Sheils and JJ O'Leary. , Transcriptome profiling of primary and recurrent ovarian cancers. , Junior Obstetrics & Gynaecology Society, Dublin, Oct 2006, 2006
Noreen Gleeson, Conservation of ovarian function in the treatment of genital tract cancers. , Society of Pelvic Surgeons, Annual meeting, . Lyon, France , October , 2005
Kearney E, Gleeson N., Gynaecological and Obstetrical Case Studies in Clinical Education Programme, 2005, - 4-10
O'Toole SA, Laios A, Sheppard BL, Gleeson NC, D'Arcy T, Mc Guinness EPJ, Bonnar J, Sheils O, O'Leary JJ. , Potential Predictors of Chemotherapy Response in Ovarian Cancer, Irish Society of Gynaecological Oncology, Belfast, 2005, 2005
Fay L, Deane R, Gleeson N., Primary adenocarcinoma of the appendix imitating appendix cancer., Irish Gynaecological Society., Belfast, May 2005, 2005
O'Toole SA, Laois A, Sheppard BL, Gleeson NC, D'Arcy T, McGuinness EPJ, Bonnar J. Sheils O, O'Leary JJ., Potential predictors of chemotherapy response in ovarian cancer., Irish Gynaecological Society., Belfast, May 2005, 2005
O'Toole SA, Laios A, Sheppard BL, Gleeson NC, D'Arcy T, Mc Guinness EPJ, Bonnar J, Sheils O, O'Leary JJ. , Angiogenesis markers in ovarian cancer act as prognostic markers but not indicators of chemotherapy response. , Pathological Society of Great Britain and Ireland, Newcastle, 2005, 2005
Duignan A, Gleeson N, D'Arcy T, McKnight D., Gynaecological Cancer audit 2001-4, Irish Cancer Data Managers Association and British Oncology Data Managers Association Conference., Dublin , 2005, 2005
O'Toole SA, Sheppard BL, D'Arcy T, McGuinness EPJ, Gleeson N, Bonnar J. Sheils O, O'Leary J., Multidrug resistance gene only plays a role in some ovarian cancers., Irish Association for Research in Cancer., Kilkenny, Ireland, March 2005, 2005
O'Toole SA, Sheppard BL, D'Arcy T, McGuinness EPJ, Gleeson N, Bonnar J, Sheils O, O'Leary J., Angiogenesis in ovarian cancer does not predict the response to chemotherapy, Irish Association for Research in Cancer, March 2005, 2005
) O'Toole SA, Sheppard BL, D'Arcy T, Mc Guinness EPJ, Gleeson NC, Bonnar J, Sheils O, O'Leary JJ. , Angiogenesis in Ovarian Cancer does not predict response to chemotherapy. , Irish Association for Cancer Research, Kilkenny, Ireland, 2005, 2005
O'Toole SA, Sheppard BL, D'Arcy T, Mc Guinness EPJ, Gleeson NC, Bonnar J, Sheils O, O'Leary JJ. , Multidrug resistance gene only plays a role in some ovarian cancers, Irish Association for Cancer Research, Kilkenny, Ireland, 2005, 2005
) Breathnach F, Laabei S, Jeffers M, Kennedy J, Hollywood D, O'Leary J, Gaffney E, D'Arcy T, Gleeson N., Clear cell carcinoma arising in the abdominal wall following hysterectomy and bilateral oophorectomy for endometriosis: A case report and literature review, Irish Gynaecological Oncology Society, Cork, 2004, 2004
Dunn E, Otokoya F, Abdulrahim M, Gleeson N, McMenamin M, Synchronous Gynaecological Tumours, Irish Gynaecological Oncology Society, Dublin, May 2003, 2003
Alarab M, Treacy A, Gleeson N., Review of stoma surgery in a Gynaecological Oncology Service over a 5 year period, European Society of Gynaecological Oncology (ESGO), Brussels, April 2003, 2003
Alarab M, Treacy A, Gleeson N , Review of stoma surgery in gynaecologic oncology patients , International Journal of Gynecological Cancer , 13, (Suppl 1), 2003, pp112-
Noreen Gleeson, Gynaecological oncology audit , Institute of Obstetrics & Gynaecology, Four Provinces Meeting, Dublin , November , 1999
Woo YL, Donnelly J, Gleeson N., Cervical cancer in post renal transplant patients, Irish Gynaecological Oncology Society, Belfast, Nov 1998, 1998
Noreen Gleeson, Ovarian transposition with radical hysterectomy. , Grand Rounds, Coombe Women's Hospital., Dublin, September, 1998
O'Donoghue K, Gleeson N., Venous thromboembolism as a presentation of gynaecological malignancy, Irish Gynaecological Oncology Society, Belfast, Nov 1998, 1998
Conway U, Gleeson N, Turner M, O'Connor H, Prendiville W, Barry-Walsh C, The conservative management of early carcinoma of the cervix, Irish Gynaecological Oncology Society, Belfast, Nov 1998, 1998
Noreen Gleeson, Fertility sparing surgery in gynaecological cancer treatment. , Gynaecology Symposium, Coombe Women's Hospital, November, 1998
Mocanu E, Gleeson NC, Laparotomy in pregnancy - how safe is it, Irish Perinatal Society , Dublin, March 1998, 1998
Woo Yin Ling, Gleeson NC., Thrombotic thrombocytopaenic purpura in pregnancy, Junior Obstetrics and Gynaecology Society, Dublin, Nov 1997, 1997
Noreen Gleeson, Lymphadenectomy in gynaecological cancers , Guinness Lecture Series, Coombe Women's Hospital, November , 1996
Cotter A, Gleeson NC, Anti-Yo antibodies and gynaecological malignancies, Junior Obstetrics and Gynaecology Society, Dublin, Nov 1996, 1996
Noreen Gleeson, Rectosigmoid resection in ovarian cancer, Society of Pelvic Surgeons Annual Meeting , Dublin, September, 1996
Gleeson NC, Hill BJ, Moscinski LC, Mark JE, Roberts WS, Hoffman MS, Fiorica JV, Cavanagh D, Urokinase and plasminogen activator inhibitor-type 2 (PAI-2): markers of tumour virulence in cervical cancer, 27th British Congress of Obstetrics and Gynaecology, Dublin, July 1995, 1995
Coulter J, Gleeson N, Turner M, Epidural analgesia and maternal pyrexia in labour: time for a re-think, Irish Perinatal Society, Galway, march 1995, 1995
Noreen Gleeson, Gynaecological oncology audit , Grand Rounds , Coombe Women's Hospital, June , 1995
Noreen Gleeson, An update on the staging and management of endometrial cancer , Irish Institute of Obstetricians and Gynaecologists. Autumn meeting, Dublin, September, 1994
Noreen Gleeson, Plasminogen activators in gynaecologic malignancies, Inaugaral Meeting of the Denis Cavanagh Society, Orlando, Florida, February, 1994
Hoffman M, Gleeson N, Finan M, Roberts W, Hoffman M, Fiorica J, Cavanagh D. , Palliative interval surgery for patients with cancer of the cervix, Society of Gynecologic Oncology, Orlando, Florida, Feb 1994, 1994
Fiorica JV, Finan M, Hoffman M, Gleeson N, Mark J, Roberts W, Cavanagh D., Massive intraoperative pelvic hemorrhage controlled by intra abdominal tamponade, Society of Memorial Gynecologic Oncologists, Williamsburg, Virginia, U.S.A., October 1993, 1993
no, Pelvic exenteration, Grand Rounds , Coombe Women's Hospital, November , 1993
Hoffman MS, Gleeson N, Finan M, Roberts W, Fiorica JV, Cavanagh D., Palliative intestinal surgery for patients with carcinoma of the cervix, Society of Gynecologic Oncologists, Palm Desert, California, February 1993, 1993
Gleeson NC, Fiorica JVF, Hoffman MS, Roberts W S, Cavanagh D. , Continent urinary diversion in Gynecologic Oncology, Irish Gynaecological Oncology Society, Dublin, October 1993, 1993
Gleeson NC, Baile W, Roberts WS, Hoffman MS, Fiorica JV, Finan MA, Barton DP, Cavanagh D, Pudendal thigh fasciocutaneous flaps for vaginal reconstruction in gynecologic cancer patients, Society of Gynecologic Oncologists., Palm Desert, California, February 1993, 1993
Gleeson NC, Plasminogen activators and their inhibitors - markers of malignant transformation of the endometrium, American Radium Society, Aruba, April 1993, 1993
Fiorica JV, Gleeson N, Cavanagh D., Pudendal thigh fasciocutaneous flaps for vginal reconstruction in gynecologic oncology. , International Society for the Study of Vulvar Disease, Quebec, Canada , September 1993, 1993
Noreen Gleeson, Cervical cancer in pregnancy, Grand Rounds, Tampa General Hospital, Florida, February, 1993
Fiorica JV, Gleeson N, Roberts W, Hoffman M, Barton D, Cavanagh D. , Venous access in gynecologic oncology patients - A comparative study of two devices, Annual Clinical Congress of the American College of Surgeons, San Francisco, California, Oct 1993, 1993
Roberts WS, Gleeson N, Miguel R., Lower extremity radiculopathy as a life expectancy indicator in patients with recurrent cervical carcinoma, Fourth Biennial Meeting of the International Gynecologic Cancer Society., Stockholm, Sweden, Sept 1993, 1993
Noreen Gleeson, Plasminogen activators and plasminogen activator inhibitors in endometrial adenocarcinoma, The American Gynecologic Club, Tampa, Florida, November, 1992
Gleeson N, Gonsalves R, Bonnar J., Urokinase (u-PA) and plasminogen inhibitor type 2 (PAI-2) in endometrial cancer, Society of Gynecologic Oncologists, San Antonio, Texas , March 1992, 1992
Fiorica J, Lockhart J, Pow-Sang J, Roberts W, Hoffman M, Barton D, Finan M, Gleeson N, Cavanagh D, Continent ileocolonic urinary diversion in conjunction with pelvic exenteration for gynecologic malignancies, American College of Obstetricians and Gynecologists, Las Vegas, Nevada , April 1992, 1992
Fiorica JV, Gleeson N, Wilson J, Roberts WS, Hoffman M, Finan M, Barton D,Cavanagh D., Weekly methotrexate and Goldstein regimen in nonmetastatic gestational trophoblastic disease (NMGTD, American College of Obstetricians and Gynecologists. District IV Annual District Meeting., San Juan, Puerta Rico. , November 1992, 1992
Roberts WS, Gleeson N, LaPolla JP, Fiorica JV, Hoffman MS, Barton DP, Finan M., Vaginal reconstruction after gynecologic cancer surgery using the pudendal thigh flap, 20th Annual Meeting of the Western Association of Gynecologic Oncologists, Durango, Colorado, June 1992, 1992
Norris LA, Gleeson N, Sheppard BL, Bonnar J., Whole blood platelet function in severe pre-eclampsia and normotensive intrauterine growth retardation (IUGR, 26th British Congress of Obstetrics & Gynaecology., Manchester, U.K., July 1992, 1992
Gleeson N, Gonsalves R, Bonnar J., Tissue plasminogen activator and urokinase in endometrial cancer, Presented to the Seventh International Meeting of Gynaecological Oncology and First World Convention of Gynaecological Oncology., Venice , April 1991, 1991
Gleeson N, Wingfield M, Bonnar J. , Plasminogen activators and inhibitors in endometrial cancer, British Gynaecological Cancer Society Scientific Meeting, Dublin, April 1991, 1991
Norris LA, Gleeson N, Sheppard BL, Bonnar J., Whole blood platelet aggregation in moderate and severe pre-eclampsia, Joint British-Dutch Hypertension Meeting, Noordwijkerhuit, Holland., June 1991, 1991
Gleeson N, Gonsalves R, Quigley J, McGuinness, Bonnar J., Plasminogen activator inhibitors in normal and malignant postmenopausal endometrium, Royal Academy of Medicine, Section of the Biological Sciences, Dublin, Jan 1991, 1991
Boyle C, Sheppard B, Gleeson N, Bonnar J., Plasminogen activator inhibitors 1 and 2 in pre-eclampsia and intrauterine fetal growth retardation, Royal Academy of Medicine in Ireland, Section of Biological Sciences. , Belfast, June 1990, 1990
Gleeson N, Sheppard BL, Boyle C, Daly L, Bonnar J., Fibrinolysis in pre-eclampsia (PET) and in pre-eclampsia with intrauterine growth retardation (PET/IUGR), XIIth European Congress of Perinatal Medicine, Lyons, France, Sept 1990, 1990
Gleeson N, Sheppard BL, Boyle C, Daly L, Bonnar J., Fibrinolysis in pre-eclampsia (PET) and in pre-eclampsia with intrauterine growth retardation (PET/IUGR), Irish Perinatal Society, Portlaoise, Ireland, Sept 1990, 1990
Gleeson N, Gormally S, Morrison J, O'Regan M., Kjellands forceps and vacuum delivery: a comparative study, Irish Perinatal Society, Portlaoise, Ireland, Sept 1990, 1990
Gleeson N, Gonsalves R, Bonnar J., Sarcoma of the uterus, Irish Junior Obstetrics & Gynaecology Society, Dublin, Dec 1990, 1990
Norris L, Gleeson N, Sheppard BL, Bonnar J., Studies in whole blood platelet aggregation in patients with pre-eclampsia and IUGR, Irish Junior Obstetrics & Gynaecology Society, Dublin, Dec 1990, 1990
Morrison J, Gleeson N, Gormally S., Instrumental rotational deliveries, Irish Junior Obstetrics & Gynaecology Society, Dublin, Dec 1990, 1990
Gleeson N, Gonsalves R, Quigley J, Wingfield M, Bonnar J. , Plasminogen activators in endometrial adenocarcinoma, Irish Gynaecological Oncology Society, Galway, November 1990, 1990
Boyle C, Sheppard BL, Gleeson N, Bonnar J. , Plasminogen activator and inhibitors in pre-eclampsia and IUGR, VII World Congress on Hypertension in Pregnancy. , Perugia, October 1990, 1990
Gleeson N, Nolan K., Core and peripheral temperature changes in parturients with epidural analgesia, Royal Academy of Medicine in Ireland, Obstetric Section. Dublin. January 1989., Dublin, Jan 1989, 1989
Sheppard B, Gleeson N, Boyle C, Daly L, Jordan M, Bonnar J., Uteroplacental fibrinolysis in intrauterine fetal growth retardation, Irish Perinatal Society, Galway, March 1989, 1989
Griffith AP, Gleeson NC., Delayed maternal effort in the second stage of actively managed labour in primiparae with epidural analgesia, British Obstetric Anaesthetists Association, Symposium on Epidural Analgesia., Bristol, U.K., Sept 1989, 1989
Sheppard B, Boyle C, Gleeson N, Jordan M, Daly L, Bonnar J. , Uteroplacental plasminogen activator and inhibitor at delivery in normotensive and hypertensive pregnancy, International Society for the Study of Hypertension in Pregnancy, Bristol, U.K., Sept 1989, 1989
Sheppard B, Gleeson N, Boyle C, Daly L, Jordan M, Bonnar J., Uteroplacental fibrinolysis in intrauterine fetal growth retardation, Irish Perinatal Society, Galway, March 1989, 1989
Sheppard B, Gleeson N, Daly L, Jordan M, Bonnar J., Uteroplacental fibrinolysis in normal pregnancy, pre-eclampsia and intrauterine fetal growth retardation: preliminary observations - tissue plasminogen activator, 20th International Meeting of the Organisation Gestosis, Cork, Ireland, July 1988, 1988
Gleeson N, Griffith A., Delayed Maternal Effort with Lumber Epidural Analgesia in Labour. A prospective study of 324 parturients., Royal Academy of Medicine in Ireland, Dublin, Jan 1988, 1988
Gleeson N., Prenatal Diagnosis of Urethral Obstruction, Royal Academy of Medicine in Ireland, Dublin, MArch 1988, 1988
Gleeson N, Griffith A., The effects of delayed maternal effort in second stage on the fetus, Irish Perinatal Society, March 1988, 1988
Griffith A, Gleeson N., Delayed Pushing in Second Stage with Lumber Epidural Analgesia, European Society of Regional Anaesthesia. , Dublin, Sept 1987, 1987
Research Expertise
Projects
- Title
- Current Clinical Trial - Clinical Trials Ireland/Gynaecolgocial Cancer Intergroup (GCIG) - St James's Hospital
- Summary
- Cervical Cancer - SHAPE trial - National P.I. for GCIG international multicentre prospective randomised study of hysterectomy with and without parametrectomy in the surgical treatment of early cervical cancer
- Funding Agency
- ICORG/ Clinical Trial Ireland
- Date From
- 2015
- Date To
- 2020
- Title
- LUSTIC
- Summary
- A study of lavage of the uterine cavity in detection of STIC lesions in the fallopian tubes. [Principal Irish Investigator]
- Funding Agency
- University of Vienna
- Date From
- 2015
- Date To
- 2020
- Title
- BioRAIDS
- Summary
- Biomarker evaluation in advanced cervical cancer. [P.I. Dr Suzy Scholl]
- Funding Agency
- Institut Curie, Paris
- Date From
- 2016
- Date To
- 2018
- Title
- A risk model for prediction of venous thromboembolism in gynaecological cancer patients following surgery
- Funding Agency
- Health Research Board [Co-P.I. with Dr Lucy Norris]
- Date From
- 2013
- Date To
- 2017
- Title
- Towards increased awareness and understanding of the risk of thrombosis in gynaecological cancers
- Summary
- co-P.I. Lucy Norris, Sharon O'Toole, Noreen Gleeson
- Funding Agency
- Health Research Board
- Date From
- 2016
- Date To
- 2017
- Title
- Non-coding miRNAs as regulators of chemoresistance in ovarian cancer
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Royal City of Dublin Hospital Trust Fund.
- Date From
- 2011
- Date To
- 2014
- Title
- A therapeutic roadmap for ovarian cancer using MyD88 and MAD2 as prognostic indicators
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Royal City of Dublin Hospital Trust
- Date From
- 2012
- Date To
- 2015
- Title
- The role of tissue factor in the transition from endometriosis to clear cell cancer.
- Funding Agency
- : Leo Pharma IIS/Gynaecological Cancer Fund, SJH [P.I. Co-applicant with Dr Lucy Norris]
- Date From
- 2013
- Date To
- 2017
- Title
- Thromboelastography as a predictor of venous thrombosis in gynaecological oncology patients undergoing surgery.
- Funding Agency
- Gynaecological Cancer Fund, SJH [P.I. Co-applicant with Dr Lucy Norris]
- Date From
- 2012
- Date To
- 2015
- Title
- Interrogation of the Onco-metabolome in ovarian cancer
- Funding Agency
- Royal City of Dublin Hospital Trust (Co-applicant with Dr. Sharon O'Toole]
- Date From
- 2013
- Date To
- 2016
- Title
- Endogenous thrombin potential (ETP) and microparticle tissue factor(TF) activity as markers of venous thromboembolism in gynaecological cancer patients.
- Funding Agency
- Leo Pharma IIS/Gynaecological Oncology Fund SJH [Co-applicant with Dr Lucy Norris]
- Date From
- 2010
- Date To
- 2013
- Title
- . Study of Tissue Factor & TF Inhibitor in Ovarian Cancer.
- Funding Agency
- Leo Pharma IIS/Gynaecological Cancer Fund, SJH [Co-applicant with Dr Lucy Norris]
- Date From
- 2009
- Date To
- 2013
- Title
- CERVIVA 2: building capacity and advancing research and patient care in cervical screening and other HPV associated diseases in Ireland
- Funding Agency
- Health Research Board. Collaborative Applied Research Grant [P.I. Professor John O'Leary]
- Date From
- 2012
- Date To
- 2017
- Title
- Systems biology approaches to cervical pre-cancer and cancer SYSTEMCERV
- Funding Agency
- European Union 7th Framework Programme. FP7-Health HEALTH-2012.2.1.2-1 [Systems Medicine: SME driven
- Date From
- 2012
- Date To
- 2014
- Title
- What is the circulating tumour cell and the role of the immune editing in the metastatic cascade?
- Funding Agency
- Body: Health Research Board. [P.I. Professor John O'Leary]
- Date From
- 2012
- Date To
- 2017
- Title
- A therapeutic roadmap for ovarian cancer using MyD88 and MAD2 as prognostic indicators
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Royal City of Dublin Hospital Trust
- Date From
- 2012
- Date To
- 2015
- Title
- What is the circulating tumour cell and the role of the immune editing in the metastatic cascade?
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Health Research Board.
- Date From
- 2012
- Date To
- 2016
- Title
- CERVIVA 2: building capacity and advancing research and patient care in cervical screening in Ireland.
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Health Research Board.
- Date From
- 2011
- Date To
- 2016
- Title
- Antibody and proteomic profiling in ovarian cancer
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Emer Casey Foundation
- Date To
- 2012
- Title
- Isolation and characterization of ovarian cancer stem cells
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Emer Casey Foundation.
- Date From
- 2009
- Date To
- 2012
- Title
- Chemoresistance and the development of novel therapeutics for ovarian cancer
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- Emer Casey Foundation.
- Date From
- 2008
- Date To
- 2012
- Title
- The role of TLR 4 in ovarian cancer stem cell biology
- Summary
- P.I. Professor John O'Leary
- Funding Agency
- The Irish Cancer Society.
- Date From
- 2008
- Date To
- 2011
Recognition
Representations
Lead clinician for gynaecological oncology to Trinity St James's Cancer Institute
Lead Gynaecological Oncologist National Guidelines Committee, National Cancer Control Programme (NCCP)
Advisor/Gynaecological Cancer Expert Panel Irish Cancer Society, Institute of Obstetricians & Gynaecologists of Ireland and Ovacare Patient Support Group
Lead gynaecological oncologist for St James's hospital group to NCCP Gynaecology Subgroup
Awards and Honours
The Master's Travel Prize, Coombe Women's Hospital. "Gastrostomy in gynaecological cancer surgery" - presentation to the Society of Gynecologic Oncologists.
Young Oncologist award received from the American Radium Society. "Plasminogen activators and their inhibitors - markers of malignant transformation of the endometrium".
First prize for presentation to the Irish Perinatal Society. "The effects of delayed maternal effort in second stage on the foetus".
Memberships
Member of the Society of Pelvic Surgeons
Member of Royal College of Obstetricians and Gynaecologists
Member of Irish Institute of Obstetricians and Gynaecologists
Member of Royal Academy of Medicine in Ireland
Member of European Society of Gynaecological Oncology
Member of International Gynaecological Cancer Society
Member of Cancer Clinical Trials Ireland
Gynaecologic Cancer Intergroup
Member of British Gynecological Cancer Society
European Organization for Research and Treatment of Cancer (EORTC)
Member of European Society of Endoscopic Surgeons